UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarter Ended March 31, 2025

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 814-00754

SLR INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

Maryland	26-1381340
(State of Incorporation)	(I.R.S. Employer Identification No.)
500 Park Avenue New York, N.Y.	10022
(Address of principal executive offices)	(Zip Code)

(212) 993-1670

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share	SLRC	The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒ No☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes☒ No☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐ No☒

The number of shares of the registrant’s Common Stock, $0.01 par value, outstanding as of May 5, 2025 was 54,554,634.

SLR INVESTMENT CORP.

FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2025

TABLE OF CONTENTS

		PAGE
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements
	Consolidated Statements of Assets and Liabilities as of March 31, 2025 (unaudited) and December 31, 2024	3
	Consolidated Statements of Operations for the three months ended March 31, 2025 (unaudited) and the three months ended March 31, 2024 (unaudited)	4
	Consolidated Statements of Changes in Net Assets for the three months ended March 31, 2025 (unaudited) and the three months ended March 31, 2024 (unaudited)	5
	Consolidated Statements of Cash Flows for the three months ended March 31, 2025 (unaudited) and the three months ended March 31, 2024 (unaudited)	6
	Consolidated Schedule of Investments as of March 31, 2025 (unaudited)	7
	Consolidated Schedule of Investments as of December 31, 2024	15
	Notes to Consolidated Financial Statements (unaudited)	23
	Report of Independent Registered Public Accounting Firm	45
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	46
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	67
Item 4.	Controls and Procedures	68
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	69
Item 1A.	Risk Factors	69
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	69
Item 3.	Defaults Upon Senior Securities	69
Item 4.	Mine Safety Disclosures	69
Item 5.	Other Information	69
Item 6.	Exhibits	70
	Signatures	71

PART I. FINANCIAL INFORMATION

In this Quarterly Report, “Company,” “we,” “us,” and “our” refer to SLR Investment Corp. unless the context states otherwise.

Item 1. Financial Statements

SLR INVESTMENT CORP.

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES

(in thousands, except share and per share amounts)

	March 31, 2025 (unaudited)			December 31, 2024
Assets
Investments at fair value:
Companies less than 5% owned (cost: $1,015,960 and $1,019,357, respectively)	$	1,021,278		$	1,027,457
Companies 5% to 25% owned (cost: $105,224 and $103,655, respectively)		89,490			89,945
Companies more than 25% owned (cost: $918,904 and $916,554, respectively)		893,631			888,232
Cash		19,931			16,761
Cash equivalents (cost: $447,074 and $397,510, respectively)		447,074			397,510
Dividends receivable		17,423			15,375
Interest receivable		11,645			11,993
Receivable for investments sold		1,336			1,573
Prepaid expenses and other assets		1,164			571
Total assets	$	2,502,972		$	2,449,417
Liabilities
Debt ($1,048,260 and $1,041,093 face amounts, respectively, reported net of    unamortized debt issuance costs of $8,848 and $9,399, respectively. See note 7)	$	1,039,412		$	1,031,694
Payable for investments and cash equivalents purchased		447,074			397,510
Management fee payable (see note 3)		7,513			7,739
Performance-based incentive fee payable (see note 3)		5,523			5,920
Interest payable (see note 7)		6,040			7,836
Administrative services payable (see note 3)		4,084			3,332
Other liabilities and accrued expenses		2,841			2,460
Total liabilities	$	1,512,487		$	1,456,491
Commitments and contingencies (see note 9)
Net Assets
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares    authorized, respectively, and 54,554,634 and 54,554,634 shares issued and    outstanding, respectively	$	546		$	546
Paid-in capital in excess of par		1,117,606			1,117,606
Accumulated distributable net loss		(127,667	)		(125,226	)
Total net assets	$	990,485		$	992,926
Net Asset Value Per Share	$	18.16		$	18.20

See notes to consolidated financial statements.

3

SLR INVESTMENT CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

(in thousands, except share and per share amounts)

	Three months ended
	March 31, 2025			March 31, 2024
INVESTMENT INCOME:
Interest:
Companies less than 5% owned	$	29,174		$	41,004
Companies 5% to 25% owned		1,224			831
Companies more than 25% owned		3,235			3,338
Dividends:
Companies 5% to 25% owned		770			—
Companies more than 25% owned		17,796			12,227
Other income:
Companies less than 5% owned		874			574
Companies more than 25% owned		105			125
Total investment income		53,178			58,099
EXPENSES:
Management fees (see note 3)		7,513			7,882
Performance-based incentive fees (see note 3)		5,526			5,952
Interest and other credit facility expenses (see note 7)		15,840			18,188
Administrative services expense (see note 3)		1,361			1,376
Other general and administrative expenses		835			895
Total expenses		31,075			34,293
Performance-based incentive fees waived (see note 3)		(2	)		(46	)
Net expenses		31,073			34,247
Net investment income	$	22,105		$	23,852
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND    CASH EQUIVALENTS:
Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned)	$	(422	)	$	135
Net change in unrealized gain (loss) on investments and cash equivalents:
Companies less than 5% owned		(2,780	)		3,484
Companies 5% to 25% owned		(2,027	)		1
Companies more than 25% owned		3,050			399
Net change in unrealized gain (loss) on investments and cash equivalents		(1,757	)		3,884
Net realized and unrealized gain (loss) on investments and cash equivalents		(2,179	)		4,019
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS	$	19,926		$	27,871
EARNINGS PER SHARE (see note 5)	$	0.37		$	0.51

See notes to consolidated financial statements.

4

SLR INVESTMENT CORP.

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (unaudited)

(in thousands, except share amounts)

	Three months ended
	March 31, 2025			March 31, 2024
Increase (decrease) in net assets resulting from operations:
Net investment income	$	22,105		$	23,852
Net realized gain (loss)		(422	)		135
Net change in unrealized gain (loss)		(1,757	)		3,884
Net increase in net assets resulting from operations		19,926			27,871
Distributions to stockholders:
From net investment income		(22,105	)		(22,367	)
From return of capital		(262	)		—
Net distributions to stockholders		(22,367	)		(22,367	)
Total increase (decrease) in net assets		(2,441	)		5,504
Net assets at beginning of period		992,926			986,639
Net assets at end of period	$	990,485		$	992,143

See notes to consolidated financial statements.

5

SLR INVESTMENT CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

(in thousands)

	Three months ended
	March 31, 2025			March 31, 2024
Cash Flows from Operating Activities:
Net increase in net assets resulting from operations	$	19,926		$	27,871
Adjustments to reconcile net increase in net assets resulting from operations to    net cash provided by operating activities:
Net realized (gain) loss on investments and cash equivalents		422			(135	)
Net change in unrealized (gain) loss on investments		1,757			(3,884	)
Deferred financing costs/market discount amortization		758			549
Net accretion of discount on investments		(1,604	)		(2,355	)
(Increase) decrease in operating assets:
Purchase of investments		(193,471	)		(100,173	)
Proceeds from disposition of investments		194,902			127,860
Capitalization of payment-in-kind income		(1,713	)		(2,799	)
Collections of payment-in-kind income		942			2,314
Receivable for investments sold		237			(11	)
Interest receivable		348			(1,097	)
Dividends receivable		(2,048	)		(24	)
Prepaid expenses and other assets		(593	)		(322	)
Increase (decrease) in operating liabilities:
Payable for investments and cash equivalents purchased		49,564			(39,421	)
Management fee payable		(226	)		(145	)
Performance-based incentive fee payable		(397	)		42
Administrative services expense payable		752			314
Interest payable		(1,796	)		(622	)
Other liabilities and accrued expenses		381			(623	)
Net Cash Provided by Operating Activities		68,141			7,339
Cash Flows from Financing Activities:
Cash distributions paid		(22,367	)		(22,367	)
Proceeds from unsecured borrowings		49,820			—
Repayment of unsecured borrowings		(85,000	)		—
Proceeds from secured borrowings		244,474			104,997
Repayment of secured borrowings		(202,334	)		(126,000	)
Net Cash Used in Financing Activities		(15,407	)		(43,370	)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		52,734			(36,031	)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		414,271			344,154
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	467,005		$	308,123
Supplemental disclosure of cash flow information:
Cash paid for interest	$	16,878		$	18,810

See notes to consolidated financial statements.

6

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited)

March 31, 2025

(in thousands, except share/unit amounts)

Description	Industry	Spread Above Index(7)	Floor			Interest Rate(1)			Acquisition Date	Maturity Date	Par Amount		Cost		Fair Value
Senior Secured Loans — 112.8%
First Lien Bank Debt/Senior Secured Loans
33Across Inc.	Media	P+232		8.50	%		10.82	%	1/2024	10/2025	$	1,722	$	1,722	$	1,722
Aegis Toxicology Sciences Corporation(16)	Health Care Providers & Services	S+550		1.00	%		10.06	%	5/2018	5/2025		13,062		13,048		13,062
Alkeme Intermediary Holdings, LLC(16)	Insurance	S+525		1.00	%		9.55	%	9/2023	10/2026		16,906		16,595		16,906
All States Ag Parts, LLC(16)	Trading Companies & Distributors	S+650(28)		1.00	%		11.06	%	4/2022	9/2026		2,065		2,051		2,065
BayMark Health Services, Inc.(16)	Health Care Providers & Services	S+500		1.00	%		9.56	%	4/2022	6/2027		8,159		7,996		8,159
Bayside Opco, LLC(24)	Health Care Providers & Services	S+725		1.00	%		11.70	%	5/2023	5/2026		19,860		19,860		19,860
Bayside Parent, LLC(24)	Health Care Providers & Services	S+1000(11)		1.00	%		14.45	%	5/2023	5/2026		6,225		6,225		6,225
BDG Media, Inc.	Media	P+525		5.50	%		12.75	%	7/2022	7/2025		3,737		3,737		3,737
CC SAG Holdings Corp.(Spectrum Automotive)(16)	Diversified Consumer Services	S+525		0.75	%		9.57	%	6/2021	6/2028		30,124		29,761		30,124
Copper River Seafoods, Inc.	Food Products	P+275		—			10.25	%	12/2023	4/2025		2,159		2,159		2,159
CVAUSA Management, LLC(16)	Health Care Providers & Services	S+525		1.00	%		9.57	%	5/2023	5/2029		41,077		40,275		41,077
DeepIntent, Inc.	Media	P+185		5.25	%		9.35	%	12/2023	9/2027		43,102		43,102		43,102
Enhanced Permanent Capital, LLC(3)	Capital Markets	S+700		1.00	%		11.43	%	12/2020	12/2025		58,078		57,683		58,078
EyeSouth Eye Care Holdco LLC	Health Care Providers & Services	S+550		1.00	%		9.92	%	10/2022	10/2029		9,920		9,678		9,920
FE Advance, LLC & Sonic ACA Advance LLC(16)	Financial Services	S+650		1.00	%		10.83	%	7/2024	7/2027		20,894		20,549		20,894
Fertility (ITC) Investment Holdco, LLC	Health Care Providers & Services	S+650		1.00	%		10.74	%	1/2023	1/2029		22,311		21,840		22,311
Human Interest Inc.(16)	Professional Services	S+735		1.00	%		11.67	%	6/2022	7/2027		20,104		20,144		20,104
iCIMS, Inc.	Software	S+575		0.75	%		10.04	%	8/2022	8/2028		31,829		31,499		31,829
Kingsbridge Holdings, LLC(2)	Multi-Sector Holdings	S+700		1.00	%		11.47	%	12/2018	12/2027		100,500		100,299		100,500
Logix Holding Company, LLC(16)	Communications Equipment	S+575		1.00	%		10.08	%	9/2018	4/2025		14,009		13,998		13,449
Luxury Asset Capital, LLC(16)	Consumer Finance	S+675		1.00	%		11.19	%	7/2022	7/2027		30,500		30,180		30,500
Maxor Acquisition, Inc.(16)	Health Care Providers & Services	S+600		1.00	%		10.43	%	3/2023	3/2029		20,171		19,762		20,171
One Touch Direct, LLC	Commercial Services & Supplies	P+75		4.00	%		8.25	%	12/2023	3/2026		1,958		1,958		1,958
ONS MSO, LLC(16)	Health Care Providers & Services	S+625		1.00	%		10.54	%	2/2023	7/2026		27,702		27,317		27,702
Peter C. Foy & Associates Insurance Services, LLC(16)	Insurance	S+550(14)		0.75	%		9.83	%	4/2022	11/2028		16,664		16,477		16,664
Pinnacle Fertility, Inc.	Health Care Providers & Services	S+500		0.75	%		9.51	%	3/2025	3/2028		14,520		13,952		13,939
Plastic Management, LLC(16)	Health Care Providers & Services	S+500		1.00	%		9.30	%	4/2022	8/2027		16,921		16,470		16,921
Quantcast Corporation	Commercial Services & Supplies	S+525		2.00	%		11.57	%	6/2024	6/2029		8,696		8,599		8,696
RQM+ Corp.(16)	Life Sciences Tools & Services	S+675(23)		1.00	%		11.31	%	8/2021	8/2029		23,616		23,305		22,671
RxSense Holdings LLC(16)	Diversified Consumer Services	S+500		1.00	%		9.39	%	4/2022	3/2026		2,621		2,585		2,621
Sherwood Management Co., Inc.	Specialty Retail	S+500		2.00	%		9.56	%	3/2025	3/2030		6,492		6,395		6,395
Shoes for Crews Global, LLC	Diversified Consumer Services	S+650(26)		1.00	%		10.94	%	6/2024	6/2029		3,409		3,409		3,409
Sightly Enterprises, Inc.	Media	P+475		6.00	%		12.25	%	1/2024	12/2026		4,601		4,601		4,601
Southern Lifting and Hoisting, LLC	Transportation Infrastructure	P+25		6.00	%		7.75	%	1/2025	1/2027		22,359		22,359		22,359
Southern Orthodontic Partners Management, LLC(16)	Health Care Providers & Services	S+550		1.00	%		9.80	%	6/2022	7/2026		33,074		32,710		33,074
Southern Transport LLC	Transportation Infrastructure	P+25		6.00	%		7.75	%	1/2025	1/2027		11,448		11,448		11,448
SPAR Marketing Force, Inc.	Media	P+190		—			9.40	%	12/2023	10/2025		12,193		12,193		12,193
Stella & Chewy's, LLC	Consumer Staples Distribution & Retail	S+525		2.00	%		9.55	%	3/2025	3/2028		9,589		9,447		9,445
SunMed Group Holdings, LLC(16)	Health Care Equipment & Supplies	S+550		0.75	%		9.89	%	6/2021	6/2028		14,790		14,562		14,790

See notes to consolidated financial statements.

7

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share/unit amounts)

Description	Industry	Spread Above Index(7)		Floor			Interest Rate(1)			Acquisition Date	Maturity Date	Par Amount		Cost		Fair Value
Senior Secured Loans (continued)
TAUC Management, LLC(16)	Health Care Providers & Services	S+700(27)			1.00	%		11.45	%	4/2022	2/2027	$	6,789	$	6,641	$	6,110
The Townsend Company, LLC(16)	Commercial Services & Supplies	S+500			1.00	%		9.30	%	8/2023	8/2030		19,379		18,902		19,195
Tilley Distribution, Inc.(16)	Trading Companies & Distributors	S+600			1.00	%		10.30	%	4/2022	12/2026		3,830		3,744		3,753
TPC 2022, LLC	Capital Markets	S+650			1.00	%		10.83	%	12/2024	12/2027		20,000		19,816		20,000
United Digestive MSO Parent, LLC(16)	Health Care Providers & Services	S+575			1.00	%		10.05	%	3/2023	3/2029		10,419		10,182		10,419
Urology Management Holdings, Inc.(16)	Health Care Providers & Services	S+550			1.00	%		9.80	%	2/2023	6/2027		11,879		11,673		11,879
UVP Management, LLC	Health Care Providers & Services	S+625			1.00	%		10.70	%	9/2023	9/2025		13,619		13,530		13,619
Western Veterinary Partners LLC(16)	Diversified Consumer Services	S+500			1.00	%		9.30	%	1/2024	10/2027		25,297		24,992		25,297
WMD Funding, LLC(11)	Financial Services		—		—			11.50	%	12/2024	7/2031		18,857		18,857		18,857
Total First Lien Bank Debt/ Senior Secured Loans														$	868,287	$	873,969
First Lien Life Science Senior Secured Loans
Arcutis Biotherapeutics, Inc.(3)	Pharmaceuticals	S+595			2.50	%		10.27	%	12/2021	8/2029	$	33,425	$	34,664	$	35,346
Ardelyx, Inc.(3)	Pharmaceuticals	S+400(25)			4.70	%		8.70	%	2/2022	7/2028		39,750		40,141		40,247
Centinel Spine, LLC(16)	Health Care Equipment & Supplies	S+530			4.35	%		9.65	%	2/2025	3/2030		22,460		22,259		22,236
Cerapedics, Inc.	Biotechnology	S+620			2.75	%		10.52	%	12/2022	1/2028		36,156		36,557		37,906
Meditrina, Inc.	Health Care Equipment & Supplies	S+550			3.45	%		9.82	%	12/2022	12/2027		4,630		4,710		4,723
OmniGuide Holdings, Inc. (13)	Health Care Equipment & Supplies	S+580			5.31	%		11.11	%	7/2018	11/2025		24,430		26,259		24,552
SPR Therapeutics, Inc.	Health Care Technology	S+515			4.00	%		9.47	%	1/2024	2/2029		7,299		7,301		7,537
Vapotherm, Inc.(24)	Health Care Equipment & Supplies	S+600			4.50	%		10.50	%	2/2022	9/2027		13,782		14,205		14,306
Total First Lien Life Science Senior Secured Loans														$	186,096	$	186,853
Second Lien Asset-Based Senior Secured Loans
AMF Levered II, LLC	Financial Services	S+705			1.00	%		11.48	%	12/2021	8/2028	$	29,925	$	29,752	$	29,925
FGI Worldwide LLC (3)(16)	Financial Services	S+650			1.00	%		10.83	%	4/2023	4/2028		8,206		8,067		8,206
Pasadena Private Lending Inc.(3)	Financial Services	S+750			1.00	%		11.82	%	12/2024	4/2028		9,825		9,711		9,825
Total Second Lien Asset-Backed Senior Secured Loans														$	47,530	$	47,956
Second Lien Bank Debt / Senior Secured Loans
RD Holdco, Inc.** (2)	Diversified Consumer Services	S+975(11)			1.00	%		—		12/2013	10/2026	$	18,904	$	12,297	$	7,827
Total Senior Secured Loans														$	1,114,210	$	1,116,605

See notes to consolidated financial statements.

8

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share/unit amounts)

Description	Industry	Interest Rate(1)	Acquisition Date	Maturity Date		Par Amount		Cost		Fair Value
Equipment Financing — 16.8%
A&A Crane and Rigging, LLC (10)	Commercial Services & Supplies	7.78%	3/2023	3/2028		$	51	$	51	$	51
Aero Operating LLC (10)	Commercial Services & Supplies	8.47-8.80%	2/2021	11/2026			127		127		126
AFG Dallas III, LLC (10)	Diversified Consumer Services	10.00-11.29%	8/2022	8/2026-3/2027			649		649		649
Air Methods Corporation (10)	Passenger Airlines	7.08-7.13%	11/2021	11/2026			2,430		2,448		2,430
Boart Longyear Company (10)	Metals & Mining	8.31-9.77%	5/2020	4/2025-10/2026			736		736		736
Bowman Energy Solutions, LLC (10)	Commercial Services & Supplies	7.42%	7/2022	7/1/2026			62		62		62
Carolina’s Contracting, LLC (10)	Diversified Consumer Services	8.40-8.72%	3/2023	3/2028-5/2028			1,629		1,640		1,596
CKD Holdings, Inc. (10)	Ground Transportation	8.10-8.60%	9/2022	3/2026-9/2027			1,607		1,607		1,607
Clubcorp Holdings, Inc. (10)	Hotels, Restaurants & Leisure	9.36-13.01%	5/2021	4/2025-5/2028			4,076		4,076		4,076
Complete Equipment Rentals, LLC (10)	Commercial Services & Supplies	6.75-7.15%	3/2023	4/2028-6/2028			1,435		1,419		1,411
Dongwon Autopart Technology Inc. (10)	Automobile Components	7.96%	2/2021	1/2026			499		500		499
Double S Industrial Contractors, Inc. (10)	Commercial Services & Supplies	8.60%	7/2023	8/2027			78		78		78
Drillers Choice, Inc. (10)	Commercial Services & Supplies	8.00-10.08%	10/2022	11/2027-6/2029			1,023		1,025		1,023
Environmental Protection & Improvement Company, LLC (10)	Ground Transportation	8.25%	9/2020	10/2027			3,596		3,607		3,596
Equipment Operating Leases, LLC (2)(12)	Multi-Sector Holdings	8.37%	4/2018	4/2025			2,754		2,754		2,685
Extreme Steel Crane & Rigging, LLC (10)	Commercial Services & Supplies	9.52%	3/2023	3/2027			552		554		552
First American Commercial Bancorp, Inc. (10)	Financial Services	7.50-9.00%	10/2021	10/2026-3/2027			1,379		1,380		1,379
First National Capital, LLC (10)	Financial Services	9.00%	11/2021	7/2026			2,844		2,844		2,844
GMT Corporation (10)	Machinery	10.71%	10/2018	1/2026			2,275		2,275		2,275
Hawkeye Contracting Company, LLC (10)	Construction & Engineering	10.50%	10/2021	11/2025			255		255		255
HTI Logistics Corporation (10)	Commercial Services & Supplies	9.94%	11/2018	9/2025			35		35		34
International Automotive Components Group, North America, Inc. (10)	Automobile Components	7.95%	6/2021	6/2025			505		506		505
Loc Performance Products, LLC (10)	Machinery	10.50%	12/2022	6/2027			435		435		435
Loyer Capital LLC (2)(12)	Multi-Sector Holdings	8.73-11.52%	5/2019	5/2026-9/2026			7,500		7,500		7,361
Nimble Crane LLC (10)	Commercial Services & Supplies	9.18%	7/2023	7/2028			717		717		717
No Limit Construction Services, LLC (10)	Commercial Services & Supplies	7.73%	5/2023	6/2028			89		89		89
PCX Aerostructures LLC (10)	Aerospace & Defense	9.32%	11/2022	12/2028			1,830		1,830		1,830
Rayzor’s Edge LLC (10)	Diversified Consumer Services	7.69-8.27%	5/2023	5/2030-6/2030			601		601		601
RH Land Construction, LLC & Harbor Dredging LA, Inc. (10)	Construction & Engineering	8.08%	5/2023	5/2026			58		58		58
Rotten Rock Hardscaping & Tree Service (10)	Diversified Consumer Services	8.21%	12/2022	12/2027			147		147		147
Signet Marine Corporation (10)	Transportation Infrastructure	8.50%	10/2022	6/2029			9,579		9,604		9,579
SLR Equipment Finance (2)(9)(17)	Multi-Sector Holdings	8.50%	12/2024	12/2025			4,950		4,950		4,950
Smiley Lifting Solutions, LLC(10)	Commercial Services & Supplies	7.82-8.61%	6/2022	9/2026-6/2030			4,998		4,998		4,998
Superior Transportation, Inc. (10)	Ground Transportation	10.22-10.63%	7/2017	1/2026			1,124		1,124		1,124
The Smedley Company & Smedley Services, Inc. (10)	Commercial Services & Supplies	4.07%	7/2017	1/2028			896		896		850
Trinity Equipment, Inc. (10)	Commercial Services & Supplies	8.78-8.93%	5/2023	5/2028			1,031		1,031		1,031
Trinity Equipment Rentals, Inc. (10)	Commercial Services & Supplies	7.94-7.95%	10/2021	11/2026-12/2026			123		123		123
U.S. Crane & Rigging, LLC (10)	Commercial Services & Supplies	8.73%	12/2022	9/2028			722		722		722
Wind River Environmental, LLC (10)	Diversified Consumer Services	8.43%	7/2019	10/2025			51		51		51
Worldwide Flight Services, Inc. (10)	Transportation Infrastructure	8.32-9.93%	9/2022	9/2027-8/2028			2,309		2,336		2,309
Zamborelli Enterprises Pacific Southern Foundation (10)	Diversified Consumer Services	8.91%	12/2022	1/2027			355		357		355
						Shares/Units
SLR Equipment Finance Equity Interests (2)(9)(17)*	Multi-Sector Holdings		7/2017				200		145,000		101,000
Total Equipment Financing								$	211,197	$	166,799
Preferred Equity – 3.3%
SOINT, LLC (2)(3)(4)	Aerospace & Defense	0.00%	6/2012	6/2025			—	$	5,241	$	2,500
Veronica Holdings, LLC (Vapotherm)(24)	Health Care Equipment & Supplies	9.00%(11)	9/2024		—		13,055,991		28,538		29,839
Total Preferred Equity								$	33,779	$	32,339

See notes to consolidated financial statements.

9

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share/unit amounts)

Description	Industry	Acquisition Date	Shares/Units		Cost		Fair Value
Common Equity/Equity    Interests/Warrants—69.5%
Assertio Holdings, Inc. (8)*	Pharmaceuticals	7/2023		12,510	$	51	$	8
Bayside Parent, LLC (24)*	Health Care Providers & Services	5/2023		6,526		11,411		8,046
CardioFocus, Inc. Warrants *	Health Care Equipment & Supplies	3/2017		90		51		—
Centrexion Therapeutics, Inc. Warrants *	Pharmaceuticals	6/2019		289,102		136		30
Conventus Orthopaedics, Inc. Warrants *	Health Care Equipment & Supplies	6/2016		157,500		65		—
Delphinus Medical Technologies, Inc. Warrants *	Health Care Equipment & Supplies	8/2017		444,388		74		68
Essence Group Holdings Corporation    (Lumeris) Warrants *	Health Care Technology	3/2017		260,000		129		108
KBH Topco LLC (Kingsbridge) (2)(5)(18)	Multi-Sector Holdings	11/2020		78,750,000		145,434		164,750
Meditrina, Inc. Warrants *	Health Care Equipment & Supplies	12/2022		44,049		33		26
RD Holdco, Inc. (Rug Doctor) (2)*	Diversified Consumer Services	12/2013		231,177		15,683		—
RD Holdco, Inc. (Rug Doctor) Class B (2)*	Diversified Consumer Services	12/2013		522		5,216		—
Senseonics Holdings, Inc. (3)(8)*	Health Care Equipment & Supplies	7/2019		469,353		235		308
Shoes for Crews Holdings, LLC	Diversified Consumer Services	6/2024		1,884		2,759		2,040
SLR-AMI Topco Blocker, LLC (15)(24)*	Broadline Retail	6/2023		—		24,655		10,575
SLR Business Credit (2)(3)(19)	Diversified Financial Services	4/2022		100		111,583		127,370
SLR Credit Solutions (2)(3)(20)	Diversified Financial Services	12/2012		280,303		280,737		288,250
SLR Healthcare ABL (2)(3)(21)	Diversified Financial Services	4/2022		32,839		34,335		38,000
SLR Senior Lending Program LLC (2)(3)(22)	Asset Management & Custody Banks	12/2022		—		47,875		48,438
Venus Concept Ltd. Warrants* (f/k/a    Restoration Robotics)	Health Care Equipment & Supplies	5/2018		36		110		—
Veronica Holdings, LLC (Vapotherm)(24)*	Health Care Equipment & Supplies	9/2027		293,203		330		639
Total Common Equity/Equity Interests/Warrants					$	680,902	$	688,656
Total Investments (6) — 202.4%					$	2,040,088	$	2,004,399

Description	Industry	Acquisition Date	Maturity Date	Par Amount		Cost		Fair Value
Cash Equivalents —45.2%
U.S. Treasury Bill (4.35% yield)	Government	3/2025	5/2025	$	450,000	$	447,074	$	447,074
Total Investments & Cash Equivalents — 247.6%						$	2,487,162	$	2,451,473
Liabilities in Excess of Other Assets — (147.6%)									(1,460,988	)
Net Assets — 100.0%								$	990,485

See notes to consolidated financial statements.

10

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share/unit amounts)

(1)Floating rate debt investments typically bear interest at a rate determined by reference to the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment, we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of March 31, 2025.

(2)Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the three months ended March 31, 2025 in these controlled investments are as follows:

Name of Issuer	Fair Value at December 31, 2024		Gross Additions		Gross Reductions		Realized Loss		Change in Unrealized Gain (Loss)			Fair Value at March 31, 2025		Interest/ Dividend/ Other Income
Equipment Operating Leases, LLC	$	2,812	$	—	$	131	$	—	$	4		$	2,685	$	59
Kingsbridge Holdings, LLC		100,500		—		—		—		(16	)		100,500		2,898
KBH Topco, LLC (Kingsbridge)		152,071		4,514		—		—		8,165			164,750		5,116
Loyer Capital LLC		7,361		—		—		—		—			7,361		186
RD Holdco, Inc. (Rug Doctor, common equity)		—		—		—		—		—			—		—
RD Holdco, Inc. (Rug Doctor, class B)		—		—		—		—		—			—		—
RD Holdco, Inc. (debt)		7,827		—		—		—		—			7,827		—
SLR Business Credit (revolver)		—		3,500		3,500		—		—			—		1
SLR Business Credit		125,370		—		—		—		2,000			127,370		3,800
SLR Credit Solutions		288,250		—		—		—		—			288,250		5,500
SLR Equipment Finance (equity)		107,600		—		—		—		(6,600	)		101,000		—
SLR Equipment Finance (debt)		3,000		2,750		800		—		—			4,950		86
SLR Healthcare ABL		37,850		—		—		—		150			38,000		1,630
SLR Healthcare ABL (revolver)		4,000		12,600		16,600		—		—			—		5
SLR Senior Lending Program LLC		49,091		—		—		—		(653	)		48,438		1,855
SOINT, LLC		2,500		—		—		—		—			2,500		—
	$	888,232	$	23,364	$	21,031	$	—	$	3,050		$	893,631	$	21,136

See notes to consolidated financial statements.

11

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share/unit amounts)

(3)Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of March 31, 2025, on a fair value basis, non-qualifying assets in the Company’s portfolio represented 26.5% of the total assets of the Company.

(4)The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.

(5)Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.

(6)Aggregate net unrealized appreciation for U.S. federal income tax purposes is $5,868; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $116,480 and $110,612, respectively, based on a tax cost of $1,998,531. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.

(7)Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor.

(8)Denotes a Level 1 investment.

(9)SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary, and NEFPASS LLC, a wholly-owned consolidated subsidiary.

(10)Indicates an investment that is wholly held by the Company through NEFPASS LLC.

(11)Interest is paid in kind (“PIK”).

(12)Denotes a subsidiary of SLR Equipment Finance.

(13)OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.

(14)Certain tranches have a spread of S+550 and certain tranches have a spread of S+650.

(15)Through this entity and other intermediate entities, the Company owns approximately 5.7% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.

(16)Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC. Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.

(17)See note 12 to the consolidated financial statements.

See notes to consolidated financial statements.

12

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share/unit amounts)

(18)See note 13 to the consolidated financial statements.

(19)See note 15 to the consolidated financial statements.

(20)See note 11 to the consolidated financial statements.

(21)See note 14 to the consolidated financial statements.

(22)See note 17 to the consolidated financial statements.

(23)Spread is S+200 cash / 4.75% PIK.

(24)Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the three months ended March 31, 2025 in these affiliated investments are as follows:

Name of Issuer	Fair Value at December 31, 2024		Gross Additions		Gross Reductions		Realized Gain (Loss)		Change in Unrealized Gain (Loss)			Fair Value at March 31, 2025		Interest/ Dividend Income
Bayside Opco, LLC	$	19,905	$	—	$	45	$	—	$	—		$	19,860	$	587
Bayside Parent, LLC (loan)		6,008		217		—		—		—			6,225		217
Bayside Parent, LLC (equity)		7,179		—		—		—		867			8,046		—
SLR-AMI Topco Blocker, LLC		12,778		571		—		—		(2,774	)		10,575		—
Vapotherm, Inc.		14,254		—		—		—		(7	)		14,306		420
Veronica Holdings, LLC (preferred equity)		29,182		657		—		—		(113	)		29,839		770
Veronica Holdings, LLC (common equity)		639		—		—		—		—			639		—
	$	89,945	$	1,445	$	45	$	—	$	(2,027	)	$	89,490	$	1,994

(25)Certain tranches have a spread of S+795, certain tranches have a spread of S+425 and certain tranches have a spread of S+400.

(26)Certain tranches have a spread of S+650 and certain tranches have a spread of S+700 (5.00% PIK/2.00% cash).

(27)Spread is S+600 cash / 1.00% PIK.

(28)Spread is S+600 cash / 0.50% PIK.

* Non-income producing security.

** Investment is on non-accrual status.

See notes to consolidated financial statements.

13

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)

March 31, 2025

Industry Classification	Percentage of Total Investments (at fair value) as of March 31, 2025
Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL)		27.2	%
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)		19.0	%
Health Care Providers & Services		14.1	%
Health Care Equipment & Supplies		5.6	%
Capital Markets		3.9	%
Pharmaceuticals		3.8	%
Diversified Consumer Services		3.7	%
Media		3.3	%
Asset Management & Custody Banks		2.4	%
Transportation Infrastructure		2.3	%
Commercial Services & Supplies		2.1	%
Biotechnology		1.9	%
Insurance		1.7	%
Software		1.6	%
Consumer Finance		1.5	%
Life Sciences Tools & Services		1.1	%
Professional Services		1.0	%
Communications Equipment		0.7	%
Broadline Retail		0.5	%
Consumer Staples Distribution & Retail		0.5	%
Health Care Technology		0.4	%
Specialty Retail		0.3	%
Ground Transportation		0.3	%
Trading Companies & Distributors		0.3	%
Aerospace & Defense		0.2	%
Hotels, Restaurants & Leisure		0.2	%
Machinery		0.1	%
Passenger Airlines		0.1	%
Food Products		0.1	%
Automobile Components		0.1	%
Metals & Mining		0.0	%
Construction & Engineering		0.0	%
Total Investments		100.0	%

See notes to consolidated financial statements.

14

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2024

(in thousands, except share/unit amounts)

Description	Industry	Spread Above Index(7)	Floor			Interest Rate(1)			Acquisition Date	Maturity Date	Par Amount		Cost		Fair Value
Senior Secured Loans — 112.5%
First Lien Bank Debt/Senior Secured Loans
33Across Inc.	Media	P+232		8.50	%		10.82	%	1/2024	10/2025	$	2,774	$	2,774	$	2,774
Aegis Toxicology Sciences Corporation(16)	Health Care Providers & Services	S+550		1.00	%		10.28	%	5/2018	5/2025		13,122		13,075		13,122
Alkeme Intermediary Holdings, LLC(16)	Insurance	S+575		1.00	%		10.08	%	9/2023	10/2026		16,886		16,531		16,886
All States Ag Parts, LLC(16)	Trading Companies & Distributors	S+600		1.00	%		10.59	%	4/2022	9/2026		2,034		2,016		2,034
BayMark Health Services, Inc.(16)	Health Care Providers & Services	S+500		1.00	%		9.59	%	4/2022	6/2027		8,180		7,999		8,180
Bayside Opco, LLC(24)	Health Care Providers & Services	S+725		1.00	%		11.73	%	5/2023	5/2026		19,905		19,905		19,905
Bayside Parent, LLC(24)	Health Care Providers & Services	S+1000(11)		1.00	%		14.48	%	5/2023	5/2026		6,008		6,008		6,008
BDG Media, Inc.	Media	P+525		5.50	%		12.75	%	7/2022	7/2025		6,249		6,249		6,249
CC SAG Holdings Corp.(Spectrum Automotive)(16)	Diversified Consumer Services	S+525		0.75	%		9.58	%	6/2021	6/2028		30,202		29,814		30,202
Copper River Seafoods, Inc.	Food Products	P+275		—			10.25	%	12/2023	4/2025		5,088		5,088		5,088
CVAUSA Management, LLC(16)	Health Care Providers & Services	S+650		1.00	%		10.84	%	5/2023	5/2029		17,191		16,771		17,191
DeepIntent, Inc.	Media	P+185		5.25	%		9.35	%	12/2023	9/2027		37,746		37,746		37,746
Enhanced Permanent Capital, LLC(3)	Capital Markets	S+700		1.00	%		11.97	%	12/2020	12/2025		44,578		44,220		44,578
EyeSouth Eye Care Holdco LLC	Health Care Providers & Services	S+550		1.00	%		9.96	%	10/2022	10/2029		9,625		9,383		9,625
FE Advance, LLC	Diversified Financial Services	S+650		1.00	%		10.86	%	7/2024	7/2027		20,894		20,517		20,894
Fertility (ITC) Investment Holdco, LLC	Health Care Providers & Services	S+650		1.00	%		11.74	%	1/2023	1/2029		22,368		21,871		22,368
Foundation Consumer Brands, LLC(16)	Personal Products	S+625		1.00	%		10.89	%	2/2021	2/2027		25,058		24,691		25,058
Human Interest Inc.	Internet Software & Services	S+735		1.00	%		11.90	%	6/2022	7/2027		20,104		20,104		20,104
iCIMS, Inc.	Software	S+575		0.75	%		10.38	%	8/2022	8/2028		32,245		31,887		32,245
Kaseya, Inc.(16)	Software	S+550(14)		0.75	%		9.83	%	6/2022	6/2029		24,702		24,445		24,702
Kingsbridge Holdings, LLC(2)	Multi-Sector Holdings	S+700		1.00	%		11.71	%	12/2018	12/2027		100,500		100,283		100,500
Logix Holding Company, LLC(16)	Communications Equipment	P+475		1.00	%		12.25	%	9/2018	3/2025		14,009		13,933		13,449
Luxury Asset Capital, LLC(16)	Thrifts & Mortgage Finance	S+675		1.00	%		11.42	%	7/2022	7/2027		30,500		30,149		30,500
Maxor Acquisition, Inc.(16)	Health Care Providers & Services	S+600		1.00	%		10.44	%	3/2023	3/2029		21,195		20,755		21,195
One Touch Direct, LLC	Commercial Services & Supplies	P+75		4.00	%		8.25	%	12/2023	3/2026		1,030		1,030		1,030
ONS MSO, LLC(16)	Health Care Providers & Services	S+625		1.00	%		10.84	%	2/2023	7/2026		27,772		27,317		27,772
Peter C. Foy & Associates Insurance Services, LLC(16)	Insurance	S+550(28)		0.75	%		9.83	%	4/2022	11/2028		16,706		16,508		16,706
Plastic Management, LLC(16)	Health Care Providers & Services	S+500		1.00	%		9.43	%	4/2022	8/2027		16,965		16,471		16,965
Quantcast Corporation	Commercial Services & Supplies	S+525		2.00	%		11.75	%	6/2024	6/2029		10,502		10,380		10,502
Retina Midco, Inc.(16)	Health Care Providers & Services	S+575		1.00	%		10.35	%	12/2023	1/2026		27,301		26,985		27,847
RQM+ Corp.(16)	Life Sciences Tools & Services	S+675(23)		1.00	%		11.34	%	8/2021	8/2029		23,398		23,201		22,462
RxSense Holdings LLC(16)	Diversified Consumer Services	S+500		1.00	%		9.69	%	4/2022	3/2026		2,628		2,582		2,628
Shoes for Crews Global, LLC	Diversified Consumer Services	S+650(26)		1.00	%		11.17	%	6/2024	6/2029		3,398		3,398		3,398
Sightly Enterprises, Inc.	Media	P+475		6.00	%		12.25	%	1/2024	12/2026		4,813		4,813		4,813
SLR Healthcare ABL(2)(3)(21)	Diversified Financial Services	S+650		—			10.81	%	12/2024	12/2025		4,000		4,000		4,000
Southern Orthodontic Partners Management, LLC(16)	Health Care Providers & Services	S+525		1.00	%		9.58	%	6/2022	7/2026		33,158		32,731		33,158
SPAR Marketing Force, Inc.	Media	P+190		—			9.40	%	12/2023	10/2025		9,251		9,251		9,251
SunMed Group Holdings, LLC(16)	Health Care Equipment & Supplies	S+550		0.75	%		10.19	%	6/2021	6/2028		14,828		14,584		14,828

See notes to consolidated financial statements.

15

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)

December 31, 2024

(in thousands, except share/unit amounts)

Description	Industry	Spread Above Index(7)		Floor			Interest Rate(1)			Acquisition Date	Maturity Date	Par Amount		Cost		Fair Value
Senior Secured Loans (continued)
TAUC Management, LLC(16)	Health Care Providers & Services	S+700(27)			1.00	%		11.48	%	4/2022	2/2027	$	7,002	$	6,829	$	6,302
The Townsend Company, LLC(16)	Commercial Services & Supplies	S+500			1.00	%		9.36	%	8/2023	8/2030		19,775		19,275		19,587
Tilley Distribution, Inc.(16)	Trading Companies & Distributors	S+600			1.00	%		10.48	%	4/2022	12/2026		3,688		3,590		3,615
TPC 2022, LLC	Capital Markets	S+650			1.00	%		10.88	%	12/2024	12/2027		20,000		19,802		19,800
United Digestive MSO Parent, LLC(16)	Health Care Providers & Services	S+575			1.00	%		10.08	%	3/2023	3/2029		9,956		9,723		9,956
Urology Management Holdings, Inc.	Health Care Providers & Services	S+550			1.00	%		9.83	%	2/2023	6/2027		11,909		11,683		11,909
UVP Management, LLC	Health Care Providers & Services	S+625			1.00	%		10.73	%	9/2023	9/2025		13,653		13,518		13,653
Western Veterinary Partners LLC(16)	Diversified Consumer Services	S+500			1.00	%		9.33	%	1/2024	10/2027		23,515		23,215		23,515
WMD Funding, LLC(11)	Diversified Financial Services		—		—			11.50	%	12/2024	7/2031		18,330		18,330		18,330
Total First Lien Bank Debt/ Senior Secured Loans														$	845,430	$	852,630
First Lien Life Science Senior Secured Loans
Arcutis Biotherapeutics, Inc.(3)	Pharmaceuticals	S+595			2.50	%		10.47	%	12/2021	8/2029	$	33,425	$	34,531	$	35,263
Ardelyx, Inc.(3)	Pharmaceuticals	S+400(25)			4.70	%		8.70	%	2/2022	7/2028		39,750		40,033		40,247
Cerapedics, Inc.	Biotechnology	S+620			2.75	%		10.72	%	12/2022	1/2028		36,156		36,498		37,889
Meditrina, Inc.	Health Care Equipment & Supplies	S+550			3.45	%		10.02	%	12/2022	12/2027		5,051		5,111		5,127
OmniGuide Holdings, Inc. (13)	Health Care Equipment & Supplies	S+580			5.31	%		11.11	%	7/2018	11/2025		24,500		26,044		24,622
Outset Medical, Inc.(16)	Health Care Equipment & Supplies	S+515			2.75	%		9.67	%	11/2022	11/2027		44,727		45,353		46,405
SPR Therapeutics, Inc.	Health Care Technology	S+515			4.00	%		9.67	%	1/2024	2/2029		4,866		4,872		5,021
Vapotherm, Inc.(24)	Health Care Equipment & Supplies	S+600			4.50	%		10.52	%	2/2022	9/2027		13,782		14,147		14,254
Total First Lien Life Science Senior Secured Loans														$	206,589	$	208,828
Second Lien Asset-Based Senior Secured Loans
AMF Levered II, LLC	Diversified Financial Services	S+705			1.00	%		11.67	%	12/2021	8/2028	$	29,925	$	29,741	$	29,925
FGI Worldwide LLC (3)(16)	Diversified Financial Services	S+650			1.00	%		10.86	%	4/2023	4/2028		8,206		8,058		8,206
Pasadena Private Lending Inc.(3)	Diversified Financial Services	S+750			1.00	%		11.88	%	12/2024	4/2028		9,825		9,703		9,702
Total Second Lien Asset-Backed Senior Secured Loans														$	47,502	$	47,833
Second Lien Bank Debt / Senior Secured Loans
RD Holdco, Inc.** (2)	Diversified Consumer Services	S+975(11)			1.00	%		—		12/2013	10/2026	$	18,228	$	12,297	$	7,827
Total Senior Secured Loans														$	1,111,818	$	1,117,118

See notes to consolidated financial statements.

16

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)

December 31, 2024

(in thousands, except share/unit amounts)

Description	Industry	Interest Rate(1)	Acquisition Date	Maturity Date		Par Amount		Cost		Fair Value
Equipment Financing — 18.2%
A&A Crane and Rigging, LLC (10)	Commercial Services & Supplies	7.78%	3/2023	3/2028		$	54	$	54	$	54
Aero Operating LLC (10)	Commercial Services & Supplies	8.47-9.09%	2/2021	3/2025-11/2026			259		258		259
AFG Dallas III, LLC (10)	Diversified Consumer Services	10.00-11.29%	8/2022	8/2026-3/2027			743		743		743
Air Methods Corporation (10)	Airlines	7.08-7.13%	11/2021	11/2026			2,569		2,591		2,569
Boart Longyear Company (10)	Metals & Mining	8.31-9.77%	5/2020	4/2025-10/2026			997		997		997
Bowman Energy Solutions, LLC (10)	Commercial Services & Supplies	7.42%	7/2022	7/1/2026			73		73		73
Carolina’s Contracting, LLC (10)	Diversified Consumer Services	8.40-8.72%	3/2023	3/2028-5/2028			2,912		2,932		2,912
CKD Holdings, Inc. (10)	Road & Rail	8.10-8.60%	9/2022	3/2026-9/2027			1,816		1,816		1,816
Clubcorp Holdings, Inc. (10)	Hotels, Restaurants & Leisure	9.36-13.01%	5/2021	4/2025-5/2028			4,550		4,550		4,550
Complete Equipment Rentals, LLC (10)	Commercial Services & Supplies	6.75-7.15%	3/2023	4/2028-6/2028			1,467		1,450		1,442
Dongwon Autopart Technology Inc. (10)	Auto Components	7.96%	2/2021	1/2026			658		661		658
Double S Industrial Contractors, Inc. (10)	Commercial Services & Supplies	8.60%	7/2023	8/2027			85		85		85
Drillers Choice, Inc. (10)	Commercial Services & Supplies	8.00-10.08%	10/2022	11/2027-6/2029			1,089		1,091		1,089
Environmental Protection & Improvement Company, LLC (10)	Road & Rail	8.25%	9/2020	10/2027			3,798		3,811		3,798
Equipment Operating Leases, LLC (2)(12)	Multi-Sector Holdings	8.37%	4/2018	4/2025			2,884		2,884		2,812
Extreme Steel Crane & Rigging, LLC (10)	Commercial Services & Supplies	9.52%	3/2023	3/2027			613		617		613
First American Commercial Bancorp, Inc. (10)	Diversified Financial Services	7.50-9.00%	10/2021	10/2026-3/2027			1,566		1,567		1,566
First National Capital, LLC (10)	Diversified Financial Services	9.00%	11/2021	7/2026			3,340		3,340		3,340
GMT Corporation (10)	Machinery	10.71%	10/2018	1/2026			2,496		2,497		2,496
Hawkeye Contracting Company, LLC (10)	Construction & Engineering	10.50%	10/2021	11/2025			347		347		347
HTI Logistics Corporation (10)	Commercial Services & Supplies	9.94%	11/2018	9/2025			53		53		51
International Automotive Components Group, North America, Inc. (10)	Auto Components	7.95%	6/2021	6/2025			1,001		1,002		1,001
Loc Performance Products, LLC (10)	Machinery	10.50%	12/2022	6/2027			477		477		477
Loyer Capital LLC (2)(12)	Multi-Sector Holdings	8.73-11.52%	5/2019	5/2026-9/2026			7,500		7,500		7,361
Miranda Logistics Enterprise, Inc. (10)	Construction & Engineering	7.69%	4/2023	4/2028			628		628		628
Mountain Air Helicopters, Inc. (10)	Commercial Services & Supplies	10.00%	7/2017	2/2025			114		114		114
Nimble Crane LLC (10)	Commercial Services & Supplies	9.18%	7/2023	7/2028			762		762		762
No Limit Construction Services, LLC (10)	Commercial Services & Supplies	7.73%	5/2023	6/2028			95		95		95
PCX Aerostructures LLC (10)	Aerospace & Defense	9.32%	11/2022	12/2028			1,931		1,931		1,931
Rango, Inc. (10)	Commercial Services & Supplies	9.33%	9/2019	4/2025			101		101		99
Rayzor’s Edge LLC (10)	Diversified Consumer Services	7.69-8.27%	5/2023	5/2030-6/2030			624		624		624
RH Land Construction, LLC & Harbor Dredging LA, Inc. (10)	Construction & Engineering	8.08%	5/2023	5/2026			69		69		69
Rotten Rock Hardscaping & Tree Service (10)	Diversified Consumer Services	8.21%	12/2022	12/2027			159		159		159
Signet Marine Corporation (10)	Transportation Infrastructure	8.50%	10/2022	6/2029			10,291		10,319		10,291
SLR Equipment Finance (2)(9)(17)	Multi-Sector Holdings	8.50%	12/2024	12/2025			3,000		3,000		3,000
Smiley Lifting Solutions, LLC(10)	Commercial Services & Supplies	7.82-8.61%	6/2022	9/2026-6/2030			5,195		5,195		5,195
ST Coaches, LLC (10)	Road & Rail	8.50%	7/2017	1/2025			520		520		520
Star Coaches Inc. (10)	Road & Rail	8.42%	3/2018	4/2025			1,719		1,719		1,633
Superior Transportation, Inc. (10)	Road & Rail	10.22-10.63%	7/2017	1/2026			1,346		1,346		1,346
The Smedley Company & Smedley Services, Inc. (10)	Commercial Services & Supplies	4.07%	7/2017	1/2028			970		970		901
Trinity Equipment, Inc. (10)	Commercial Services & Supplies	8.78-8.93%	5/2023	5/2028			1,085		1,085		1,085
Trinity Equipment Rentals, Inc. (10)	Commercial Services & Supplies	7.94-7.95%	10/2021	11/2026-12/2026			136		136		136
U.S. Crane & Rigging, LLC (10)	Commercial Services & Supplies	8.73%	12/2022	9/2028			766		766		766
Wind River Environmental, LLC (10)	Diversified Consumer Services	8.43%	7/2019	10/2025			72		72		72
Womble Company, Inc. (10)	Energy Equipment & Services	9.11%	12/2019	1/2025			17		17		17
Worldwide Flight Services, Inc. (10)	Transportation Infrastructure	8.32-9.93%	9/2022	9/2027-8/2028			2,465		2,495		2,465
Zamborelli Enterprises Pacific Southern Foundation (10)	Diversified Consumer Services	8.91%	12/2022	1/2027			399		401		399
						Shares/Units
SLR Equipment Finance Equity Interests (2)(9)(17)*	Multi-Sector Holdings		7/2017				200		145,000		107,600
Total Equipment Financing								$	218,920	$	181,016
Preferred Equity – 3.2%
SOINT, LLC (2)(3)(4)	Aerospace & Defense	0.00%	6/2012	6/2025			—	$	5,241	$	2,500
Veronica Holdings, LLC (Vapotherm)(24)	Health Care Equipment & Supplies	9.00%(11)	9/2024		—		13,055,991		27,769		29,182
Total Preferred Equity								$	33,010	$	31,682

See notes to consolidated financial statements.

17

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)

December 31, 2024

(in thousands, except share/unit amounts)

Description	Industry	Acquisition Date	Shares/ Units		Cost		Fair Value
Common Equity/Equity    Interests/Warrants—68.1%
Assertio Holdings, Inc. (8)*	Pharmaceuticals	7/2023		12,510	$	51	$	11
Bayside Parent, LLC (24)*	Health Care Providers & Services	5/2023		6,526		11,411		7,179
CardioFocus, Inc. Warrants *	Health Care Equipment & Supplies	3/2017		90		51		—
Centrexion Therapeutics, Inc. Warrants *	Pharmaceuticals	6/2019		289,102		136		47
Conventus Orthopaedics, Inc. Warrants *	Health Care Equipment & Supplies	6/2016		157,500		65		—
Delphinus Medical Technologies, Inc. Warrants *	Health Care Equipment & Supplies	8/2017		444,388		74		84
Essence Group Holdings Corporation    (Lumeris) Warrants *	Health Care Technology	3/2017		260,000		129		131
KBH Topco LLC (Kingsbridge) (2)(5)(18)	Multi-Sector Holdings	11/2020		76,125,000		140,920		152,071
Meditrina, Inc. Warrants *	Health Care Equipment & Supplies	12/2022		44,049		33		31
RD Holdco, Inc. (Rug Doctor) (2)*	Diversified Consumer Services	12/2013		231,177		15,683		—
RD Holdco, Inc. (Rug Doctor) Class B (2)*	Diversified Consumer Services	12/2013		522		5,216		—
Senseonics Holdings, Inc. (3)(8)*	Health Care Equipment & Supplies	7/2019		469,353		235		246
Shoes for Crews Holdings, LLC	Diversified Consumer Services	6/2024		1,884		2,759		2,040
SLR-AMI Topco Blocker, LLC (15)(24)*	Internet & Catalog Retail	6/2023		—		24,085		12,778
SLR Business Credit (2)(3)(19)	Diversified Financial Services	4/2022		100		111,583		125,370
SLR Credit Solutions (2)(3)(20)	Diversified Financial Services	12/2012		280,303		280,737		288,250
SLR Healthcare ABL (2)(3)(21)	Diversified Financial Services	4/2022		32,839		34,335		37,850
SLR Senior Lending Program LLC (2)(3)(22)	Asset Management	12/2022		—		47,875		49,091
Venus Concept Ltd. Warrants* (f/k/a    Restoration Robotics)	Health Care Equipment & Supplies	5/2018		396		110		—
Veronica Holdings, LLC (Vapotherm)(24)*	Health Care Equipment & Supplies	9/2027		293,203		330		639
Total Common Equity/Equity Interests/Warrants					$	675,818	$	675,818
Total Investments (6) — 202.0%					$	2,039,566	$	2,005,634

See notes to consolidated financial statements.

18

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)

December 31, 2024

(in thousands, except share/unit amounts)

Description	Industry	Acquisition Date	Maturity Date	Par Amount		Cost		Fair Value
Cash Equivalents —40.0%
U.S. Treasury Bill (4.24% yield)	Government	12/2024	2/2025	$	400,000	$	397,510	$	397,510
Total Investments & Cash Equivalents — 242.0%						$	2,437,076	$	2,403,144
Liabilities in Excess of Other Assets — (142.0%)									(1,410,218	)
Net Assets — 100.0%								$	992,926

(1)Floating rate debt investments typically bear interest at a rate determined by reference to the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment, we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2024.

(2)Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2024 in these controlled investments are as follows:

Name of Issuer	Fair Value at December 31, 2023		Gross Additions		Gross Reductions		Realized Loss		Change in Unrealized Gain (Loss)			Fair Value at December 31, 2024		Interest/ Dividend/ Other Income
Equipment Operating Leases, LLC	$	3,296	$	—	$	496	$	—	$	12		$	2,812	$	264
Kingsbridge Holdings, LLC		96,000		4,500		—		—		113			100,500		11,972
KBH Topco, LLC (Kingsbridge)		142,000		4,323		—		—		5,748			152,071		12,159
Loyer Capital LLC		7,361		—		—		—		—			7,361		757
RD Holdco, Inc. (Rug Doctor, common equity)		—		—		—		—		—			—		—
RD Holdco, Inc. (Rug Doctor, class B)		—		—		—		—		—			—		—
RD Holdco, Inc. (debt)		7,827		—		—		—		—			7,827		—
SLR Business Credit (revolver)		—		19,000		19,000		—		—			—		33
SLR Business Credit		90,370		30,000		—		—		5,000			125,370		8,350
SLR Credit Solutions		284,000		—		—		—		4,250			288,250		20,500
SLR Equipment Finance (equity)		120,820		—		—		—		(13,220	)		107,600		—
SLR Equipment Finance (debt)		3,850		3,000		3,850		—		—			3,000		28
SLR Healthcare ABL		35,850		—		—		—		2,000			37,850		5,123
SLR Healthcare ABL (revolver)		—		4,000		—		—		—			4,000		1
SLR Senior Lending Program LLC		43,899		5,000		—		—		192			49,091		7,262
SOINT, LLC		3,801		63		—		—		(1,364	)		2,500		62
	$	839,074	$	69,886	$	23,346	$	—	$	2,731		$	888,232	$	66,511

See notes to consolidated financial statements.

19

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)

December 31, 2024

(in thousands, except share/unit amounts)

(3)Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If the Company fails to invest a sufficient portion of our assets in qualifying assets, it could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2024, on a fair value basis, non-qualifying assets in the Company’s portfolio represented 26.3% of the total assets of the Company.

(4)The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.

(5)Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.

(6)Aggregate net unrealized appreciation for U.S. federal income tax purposes is $7,625; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $109,461 and $101,836, respectively, based on a tax cost of $1,998,009. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.

(7)Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor.

(8)Denotes a Level 1 investment.

(9)SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary, and NEFPASS LLC, a wholly-owned consolidated subsidiary.

(10)Indicates an investment that is wholly held by the Company through NEFPASS LLC.

(11)Interest is paid in kind (“PIK”).

(12)Denotes a subsidiary of SLR Equipment Finance.

(13)OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.

(14)Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.

(15)Through this entity and other intermediate entities, the Company owns approximately 5.7% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.

(16)Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC. Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.

(17)See note 12 to the consolidated financial statements.

See notes to consolidated financial statements.

20

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)

December 31, 2024

(in thousands, except share/unit amounts)

(18)See note 13 to the consolidated financial statements.

(19)See note 15 to the consolidated financial statements.

(20)See note 11 to the consolidated financial statements.

(21)See note 14 to the consolidated financial statements.

(22)See note 17 to the consolidated financial statements.

(23)Spread is S+200 cash / 4.75% PIK.

(24)Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2024 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows:

Name of Issuer	Fair Value at December 31, 2023		Gross Additions		Gross Reductions		Realized Gain (Loss)		Change in Unrealized Gain (Loss)			Fair Value at December 31, 2024		Interest/ Dividend Income
Bayside Opco, LLC	$	19,415	$	626	$	136	$	—	$	—		$	19,905	$	2,543
Bayside Parent, LLC (loan)		5,153		855		—		—		—			6,008		850
Bayside Parent, LLC (equity)		3,815		—		—		—		3,364			7,179		—
SLR-AMI Topco Blocker, LLC		15,867		—		—		—		(3,089	)		12,778		—
Vapotherm, Inc.		—		14,080		—		—		108			14,254		488
Veronica Holdings, LLC (preferred equity)		—		27,644		—		—		1,413			29,182		845
Veronica Holdings, LLC (common equity)		—		330		—		—		309			639		—
	$	44,250	$	43,535	$	136	$	—	$	2,105		$	89,945	$	4,726

(29)Certain tranches have a spread of S+795, certain tranches have a spread of S+425 and certain tranches have a spread of S+400.

(30)Certain tranches have a spread of S+650 and certain tranches have a spread of S+700 (5.00% PIK/2.00% cash).

(31)Spread is S+600 cash / 1.00% PIK.

(32)Certain tranches have a spread of S+550 and certain tranches have a spread of S+650.

* Non-income producing security.

** Investment is on non-accrual status.

See notes to consolidated financial statements.

21

SLR INVESTMENT CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)

December 31, 2024

Industry Classification	Percentage of Total Investments (at fair value) as of December 31, 2024
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL)		27.7	%
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)		18.6	%
Health Care Providers & Services		13.6	%
Health Care Equipment & Supplies		6.8	%
Pharmaceuticals		3.8	%
Diversified Consumer Services		3.3	%
Capital Markets		3.2	%
Media		3.0	%
Software		2.8	%
Asset Management		2.4	%
Commercial Services & Supplies		2.2	%
Biotechnology		1.9	%
Insurance		1.7	%
Thrifts & Mortgage Finance		1.5	%
Personal Products		1.2	%
Life Sciences Tools & Services		1.1	%
Internet Software & Services		1.0	%
Communications Equipment		0.7	%
Internet & Catalog Retail		0.6	%
Transportation Infrastructure		0.6	%
Road & Rail		0.5	%
Trading Companies & Distributors		0.3	%
Health Care Technology		0.3	%
Food Products		0.3	%
Hotels, Restaurants, & Leisure		0.2	%
Aerospace & Defense		0.2	%
Machinery		0.1	%
Airlines		0.1	%
Auto Components		0.1	%
Construction & Engineering		0.1	%
Metals & Mining		0.1	%
Energy Equipment & Services		0.0	%
Total Investments		100.0	%

See notes to consolidated financial statements.

22

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

March 31, 2025

(in thousands, except share and per share amounts)

Note 1. Organization

SLR Investment Corp. (the “Company,” “SLRC,” “we,” “us” or “our”), a Maryland corporation formed in November 2007, is an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.

The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and, to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.

On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”), pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders.

23

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

Note 2. Significant Accounting Policies

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.

Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X, as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2025.

In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of consolidated financial statements, have been included.

The significant accounting policies consistently followed by the Company are:  

(a)Investment transactions are accounted for on the trade date.

(b)Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize mid-market pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.

With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under GAAP, the Board has approved a multi-step valuation process each quarter, as described below:

(1)our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;

(2)preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;

24

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

(3)independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;

(4)the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and

(5)the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.

The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule 2a-5 under the 1940 Act; and (6) maintain recordkeeping requirements under Rule 2a-5.

Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the three months ended March 31, 2025, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.

ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.

Level 2: Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.

Level 3: Unobservable inputs for the asset or liability.

In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.

(c)Gains or losses on investments are calculated by using the specific identification method.

(d)The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized, and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other non-recurring fee income, as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned.

25

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

(e)The Company intends to comply with the applicable provisions of the Code pertaining to regulated investment companies to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.

(f)Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.

(g)Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.

(h)In accordance with Regulation S-X and ASC Topic 810—Consolidation, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.

(i)The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.

(j)In accordance with ASC 835-30, the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.

(k)The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are marked-to-market by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.

(l)The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC 946-20-25.

(m)Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.

(n)The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

26

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

Note 3. Agreements

The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the day-to-day operations of, and provides investment advisory services to, the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. On April 1, 2022, in connection with the consummation of the Mergers, we entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by us to the Investment Adviser pursuant to the Advisory Agreement. Following the Letter Agreement, the base management fee is now determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. Treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.

The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s pre-incentive fee net investment income for the immediately preceding calendar quarter. For this purpose, pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement (as defined below), and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee). Pre-incentive fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation. Pre-incentive fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s pre-incentive fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s pre-incentive fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s pre-incentive fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately pro-rated for any period of less than three months.

The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and equals 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross investment-by-investment basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three months ended March 31, 2025 and 2024.

For the three months ended March 31, 2025 and 2024, the Company recognized $7,513 and $7,882, respectively, in base management fees and $5,526 and $5,952, respectively, in performance-based incentive fees. For the three months ended March 31, 2025 and 2024, $2 and $46, respectively, of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discounts allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser. 

The Company has also entered into an administration agreement (the “Administration Agreement”) with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.

27

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

For the three months ended March 31, 2025 and 2024, the Company recognized expenses under the Administration Agreement of $1,361 and $1,376, respectively. No managerial assistance fees were accrued or collected for the three months ended March 31, 2025 and 2024.

Note 4. Net Asset Value Per Share

At March 31, 2025, the Company’s total net assets and net asset value per share were $990,485 and $18.16, respectively. This compares to total net assets and net asset value per share at December 31, 2024 of $992,926 and $18.20, respectively.

Note 5. Earnings Per Share

The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC 260-10, for the three months ended March 31, 2025 and 2024:

	Three months ended March 31,
	2025		2024
Earnings per share (basic & diluted)
Numerator - net increase in net assets resulting from    operations:	$	19,926	$	27,871
Denominator - weighted average shares:		54,554,634		54,554,634
Earnings per share:	$	0.37	$	0.51

Note 6. Fair Value

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:

Level 1. Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.

Level 2. Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:

a)Quoted prices for similar assets or liabilities in active markets;

b)Quoted prices for identical or similar assets or liabilities in non-active markets;

c)Pricing models whose inputs are observable for substantially the full term of the asset or liability; and

d)Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.

Level 3. Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.

When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).

Gains and losses for assets and liabilities categorized within the Level 3 tables below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

28

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.

The following tables present the balances of assets measured at fair value on a recurring basis, as of March 31, 2025 and December 31, 2024:

Fair Value Measurements

As of March 31, 2025

	Level 1		Level 2		Level 3		Measured at Net Asset Value*		Total
Assets:
Senior Secured Loans	$	—	$	—	$	1,116,605	$	—	$	1,116,605
Equipment Financing		—		—		166,799		—		166,799
Preferred Equity		—		—		32,339		—		32,339
Common Equity/Equity Interests/Warrants		316		—		639,902		48,438		688,656
Total Investments	$	316	$	—	$	1,955,645	$	48,438	$	2,004,399

Fair Value Measurements

As of December 31, 2024

	Level 1		Level 2		Level 3		Measured at Net Asset Value*		Total
Assets:
Senior Secured Loans	$	—	$	—	$	1,117,118	$	—	$	1,117,118
Equipment Financing		—		—		181,016		—		181,016
Preferred Equity		—		—		31,682		—		31,682
Common Equity/Equity Interests/Warrants		257		—		626,470		49,091		675,818
Total Investments	$	257	$	—	$	1,956,286	$	49,091	$	2,005,634

* In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP (as defined below). See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.

29

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

The following table provides a summary of the changes in fair value of Level 3 assets for the three months ended March 31, 2025, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at March 31, 2025:

Fair Value Measurements Using Level 3 Inputs

	Senior Secured Loans			Equipment Financing			Preferred Equity			Common Equity/ Equity Interests/ Warrants		Total
Fair value, December 31, 2024	$	1,117,118		$	181,016		$	31,682		$	626,470	$	1,956,286
Total gains or losses included in earnings:
Net realized gain (loss)		30			(8	)		—			—		22
Net change in unrealized gain (loss)		(2,905	)		(6,493	)		(113	)		8,348		(1,163	)
Purchase of investment securities*		188,200			2,734			770			5,084		196,788
Proceeds from dispositions of investment securities		(185,838	)		(10,450	)		—			—		(196,288	)
Transfers in/out of Level 3		—			—			—			—		—
Fair value, March 31, 2025	$	1,116,605		$	166,799		$	32,339		$	639,902	$	1,955,645
Unrealized gains (losses) for the period relating to those    Level 3 assets that were still held by the Company at the    end of the period:
Net change in unrealized gain (loss)	$	(367	)	$	(6,493	)	$	(113	)	$	8,348	$	1,375

* Includes PIK capitalization and accretion of discount.

While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at March 31, 2025, the fair value of the Credit Facility, SPV Credit Facility, 2026 Unsecured Notes, 2027 Unsecured Notes, 2027 Series F Unsecured Notes, 2027 Series G Unsecured Notes and the 2028 Unsecured Notes (each as defined below) would be $536,210, $153,050, $72,563, $47,000, $128,250, $48,878 and $49,750, respectively. All debt obligations would be considered Level 3 liabilities and would be valued with market yield as the unobservable input.

30

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2024, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2024:

Fair Value Measurements Using Level 3 Inputs

	Senior Secured Loans			Equipment Financing			Preferred Equity		Common Equity/ Equity Interests/ Warrants			Total
Fair value, December 31, 2023	$	1,277,539		$	256,819		$	3,801	$	572,427		$	2,110,586
Total gains or losses included in earnings:
Net realized loss		(1,400	)		—			—		(668	)		(2,068	)
Net change in unrealized gain (loss)		(3,598	)		(12,646	)		49		17,726			1,531
Purchase of investment securities*		411,598			2,852			27,832		37,434			479,716
Proceeds from dispositions of investment securities		(567,021	)		(66,009	)		—		(449	)		(633,479	)
Transfers in/out of Level 3		—			—			—		—			—
Fair value, December 31, 2024	$	1,117,118		$	181,016		$	31,682	$	626,470		$	1,956,286
Unrealized gains (losses) for the period relating to those    Level 3 assets that were still held by the Company at    the end of the period:
Net change in unrealized gain (loss)	$	1,533		$	(12,646	)	$	49	$	16,751		$	5,687

* Includes PIK capitalization and accretion of discount

While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations,
if the Company’s debt obligations were carried at fair value at December 31, 2024, the fair value of the Credit Facility, SPV Credit
Facility, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes, 2027 Series F Unsecured Notes and 2027 Series G
Unsecured Notes (each as defined below) would be $482,043, $165,050, $84,575, $72,750, $46,875, $128,250 and $49,368, respectively.

Quantitative Information about Level 3 Fair Value Measurements

The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.

Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.

31

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of March 31, 2025 is summarized in the table below:

	Asset or Liability	Fair Value at March 31, 2025		Principal Valuation Technique/Methodology	Unobservable Input	Range (Weighted Average)
Senior Secured Loans	Asset	$	1,095,329	Income Approach	Market Yield	9.4% – 26.1% (11.7%)
	Asset	$	21,276	Recovery Analysis	Recoverable Amount	N/A
Equipment Financing	Asset	$	65,799	Income Approach	Market Yield	8.5% – 9.2% (9.2%)
		$	101,000	Market Multiple(1)	Comparable Multiple	1.1x – 1.4x (1.4x)
Preferred Equity	Asset	$	29,839	Income Approach	Market Yield	9.0% – 9.0% (9.0%)
		$	2,500	Recovery Analysis	Recoverable Amount	N/A
Common Equity/Equity    Interests/Warrants	Asset	$	186,282	Market Multiple(2)	Comparable Multiple	5.5x – 12.3x (7.6x)
		$	453,620	Market Approach	Return on Equity	7.8% – 23.4% (11.7%)

(1)Includes $101,000 of investments valued using an implied multiple.

(2)Includes $232 of investments valued using a Black-Scholes model, $639 of investments valued using a transaction price, $2,040 of investments valued using a recovery analysis and $183,371 of investments valued using an EBITDA multiple.

Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2024 is summarized in the table below:

	Asset or Liability	Fair Value at December 31, 2024		Principal Valuation Technique/Methodology	Unobservable Input	Range (Weighted Average)
Senior Secured Loans	Asset	$	1,095,842	Income Approach	Market Yield	8.5% – 18.5% (11.8%)
	Asset	$	21,276	Recovery Analysis	Recoverable Amount	N/A
Equipment Financing	Asset	$	73,416	Income Approach	Market Yield	8.5% – 9.0% (9.0%)
		$	107,600	Market Multiple(1)	Comparable Multiple	1.2x – 1.5x (1.5x)
Preferred Equity	Asset	$	29,182	Income Approach	Market Yield	9.0% – 9.0% (9.0%)
		$	2,500	Recovery Analysis	Recoverable Amount	N/A
Common Equity/Equity    Interests/Warrants	Asset	$	175,000	Market Multiple(2)	Comparable Multiple	5.5x – 12.3x (9.1x)
		$	451,470	Market Approach	Return on Equity	7.8% – 21.7% (11.3%)

(1)Includes $107,600 of investments valued using an implied multiple.

(2)Includes $293 of investments valued using a Black-Scholes model, $639 of investments valued using a transaction price, $2,040 of investments valued using a recovery analysis and $172,028 of investments valued using an EBITDA multiple.

Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments. Weighted averages in the above tables are calculated based on fair value of the underlying assets.

32

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

Note 7. Debt

Our debt obligations consisted of the following as of March 31, 2025 and December 31, 2024:

	March 31, 2025					December 31, 2024
Facility	Face Amount		Carrying Value			Face Amount		Carrying Value
Credit Facility	$	536,210	$	529,372	(1)	$	482,043	$	474,715	(1)
SPV Credit Facility		153,050		151,492	(2)		165,050		163,335	(2)
2025 Unsecured Notes		—		—			85,000		84,956	(3)
2026 Unsecured Notes		75,000		74,772	(4)		75,000		74,741	(4)
2027 Unsecured Notes		50,000		49,982	(5)		50,000		49,979	(5)
2027 Series F Unsecured Notes		135,000		134,989	(6)		135,000		134,998	(6)
2027 Series G Unsecured Notes		49,000		48,893	(7)		49,000		48,970	(7)
2028 Unsecured Notes		50,000		49,912	(8)		—		—
	$	1,048,260	$	1,039,412		$	1,041,093	$	1,031,694

(1)Carrying Value equals the Face Amount net of unamortized debt issuance costs of $6,838 and $7,328 as of March 31, 2025 and December 31, 2024, respectively.

(2)Carrying Value equals the Face Amount net of unamortized debt issuance costs/market discount of $1,558 and $1,715 as of March 31, 2025 and December 31, 2024, respectively.

(3)Carrying Value equals the Face Amount net of unamortized market discount of $44 as of December 31, 2024.

(4)Carrying Value equals the Face Amount net of unamortized market discount of $228 and $259 as of March 31, 2025 and December 31, 2024, respectively.

(5)Carrying Value equals the Face Amount net of unamortized market discount of $18 and $21 as of March 31, 2025 and December 31, 2024, respectively.

(6)Carrying Value equals the Face Amount net of unamortized debt issuance costs of $11 and $2 as of March 31, 2025 and December 31, 2024, respectively.

(7)Carrying Value equals the Face Amount net of unamortized debt issuance costs of $107 and $30 as of March 31, 2025 and December 31, 2024, respectively.

(8) Carrying Value equals the Face Amount net of unamortized debt issuance costs of $88 as of March 31, 2025.

Unsecured Notes

On February 18, 2025, the Company closed a private offering of $50,000 of unsecured notes with a fixed interest rate of 6.14% and a maturity date of February 18, 2028 (the “2028 Unsecured Notes”). Interest on the 2028 Unsecured Notes is due semi-annually on February 18 and August 18. The 2028 Unsecured Notes were issued in a private placement only to qualified institutional buyers.

On December 16, 2024, the Company closed a private offering of $49,000 of unsecured notes with a fixed interest rate of 6.24% and a maturity date of December 16, 2027 (the “2027 Series G Unsecured Notes”). Interest on the 2027 Series G Unsecured Notes is due semi-annually on June 16 and December 16. The 2027 Series G Unsecured Notes were issued in a private placement only to qualified institutional buyers.

On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”), and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes was due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement to be performed or observed by SUNS. The 2025 Unsecured Notes were repaid in full at maturity on March 31, 2025.

On January 6, 2022, the Company closed a private offering of $135,000 of unsecured notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027 (the “2027 Series F Unsecured Notes”). Interest on the 2027 Series F Unsecured Notes is due

33

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.

On September 14, 2021, the Company closed a private offering of $50,000 of unsecured notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027 (the “2027 Unsecured Notes”). Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.

On December 18, 2019, the Company closed a private offering of $75,000 of unsecured notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026 (the “2026 Unsecured Notes”). Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.

Revolving and Term Loan Facilities

On August 16, 2024, the Company closed on Amendment No. 3 to its August 28, 2019 senior secured credit agreement (as amended to date, the “Credit Facility”). Following the amendment and several commitment increases in the fourth quarter of 2024, the Credit Facility is now composed of $695,000 of revolving credit and $140,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of 1.75%-2.00% or the alternate base rate plus 0.75%-1.00%. The Credit Facility has a 0% floor, matures in August 2029 and includes ratable amortization in the final year. Subsequent to Amendment No. 4 on December 3, 2024, the Credit Facility may be increased up to $900,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that, among other things, require the Company to maintain a minimum stockholder’s equity and a minimum asset coverage ratio. At March 31, 2025, outstanding USD equivalent borrowings under the Credit Facility totaled $536,210, composed of $396,210 of revolving credit and $140,000 of term loans.

On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the
closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility,
originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC
(the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and
collateral agent, and the other parties thereto. Currently, subsequent to an August 30, 2024 amendment, the commitment under the
SPV Credit Facility is $275,000. The stated interest rate on the SPV Credit Facility is SOFR plus 2.25%-2.75% with no SOFR floor
requirement and the current final maturity date is August 30, 2028. The SPV Credit Facility is secured by all of the assets held by
SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and
SUNS SPV, as applicable, have made certain customary representations and warranties and are required to comply with various
covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The
SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At March 31, 2025,
outstanding USD equivalent borrowings under the SPV Credit Facility totaled $153,050.

Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.

The average annualized interest cost for all borrowings for the three months ended March 31, 2025 and the year ended December 31, 2024 was 5.57% and 5.91%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes, the 2027 Series F Unsecured Notes, the 2027 Series G Unsecured Notes and the 2028 Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the three months ended March 31, 2025 and the year ended December 31, 2024 were $1,133,260 and $1,192,250, respectively.

34

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

Note 8. Financial Highlights

The following is a schedule of financial highlights for the three months ended March 31, 2025 and 2024:

	Three months ended March 31, 2025			Three months ended March 31, 2024
Per Share Data: (a)
Net asset value, beginning of year	$	18.20		$	18.09
Net investment income		0.41			0.44
Net realized and unrealized gain (loss)		(0.04	)		0.07
Net increase in net assets resulting from operations		0.37			0.51
Distributions to stockholders:
From distributable earnings		(0.41	)		(0.41	)
From return of capital		—			—
Net asset value, end of period	$	18.16		$	18.19
Per share market value, end of period	$	16.86		$	15.35
Total Return (b)(c)		6.82	%		4.86	%
Net assets, end of period	$	990,485		$	992,143
Shares outstanding, end of period		54,554,634			54,554,634
Ratios to average net assets (c):
Net investment income		2.23	%		2.42	%
Operating expenses	1.53%*			1.63%*
Interest and other credit facility expenses		1.60	%		1.84	%
Total expenses	3.13%*			3.47%*
Average debt outstanding	$	1,010,398		$	1,146,997
Portfolio turnover ratio		9.7	%		4.7	%

(a)Calculated using the average shares outstanding method.

(b)Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2024 and December 31, 2023 was $16.16 and $15.03, respectively. Total return does not include a sales load.

(c)Not annualized for periods less than one year.

* The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the three months ended March 31, 2025 and 2024, the ratios of operating expenses to average net assets would be 1.53% and 1.63%, respectively, without the performance-based incentive fee waiver. For the three months ended March 31, 2025 and 2024, the ratios of total expenses to average net assets would be 3.13% and 3.47%, respectively, without the performance-based incentive fee waiver.

35

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

Note 9. Commitments and Contingencies

Off-Balance Sheet Arrangements

The Company has unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare (each as defined below). The total amount of these unfunded commitments as of March 31, 2025 and December 31, 2024 was $268,648 and $234,554, respectively, comprised of the following:

	March 31, 2025		December 31, 2024
SLR Credit Solutions*	$	44,263	$	44,263
Alkeme Intermediary Holdings, LLC		25,605		—
SLR Healthcare ABL*		17,000		10,000
BDG Media, Inc.		14,263		11,751
Stella & Chewy's, LLC		13,153		—
Arcutis Biotherapeutics, Inc.		12,658		12,658
Western Veterinary Partners LLC		11,647		18,245
Plastic Management, LLC		10,806		10,806
Copper River Seafoods, Inc.		9,841		6,912
Pasadena Private Lending Inc.		8,369		8,369
SLR Business Credit*		8,000		8,000
WMD Funding LLC		7,243		7,243
One Touch Direct, LLC		7,042		7,970
Ardelyx, Inc.		6,648		6,648
United Digestive MSO Parent, LLC		6,021		7,496
Quantcast Corporation		5,878		4,071
The Townsend Company, LLC		5,741		7,923
Pinnacle Fertility, Inc.		5,280		—
33 Across Inc.		5,278		4,226
Sherwood Management Co., Inc.		4,271		—
iCIMS, Inc.		3,945		3,530
SPR Therapeutics, Inc.		3,650		6,083
Southern Transport LLC		3,552		—
CVAUSA Management, LLC		3,164		10,164
Sightly Enterprises, Inc.		2,899		2,687
Southern Lifting and Hoisting, LLC		2,641		—
SPAR Marketing Force, Inc.		2,507		5,449
Erie Construction Mid-west, LLC		2,403		2,403
SLR Senior Lending Program LLC*		2,125		2,125
Bayside Opco, LLC		2,093		2,093
DeepIntent, Inc.		1,898		7,254
SunMed Group Holdings, LLC		1,621		1,621
RxSense Holdings LLC		1,250		1,250
SLR Equipment Finance*		1,050		3,000
Tilley Distribution, Inc.		1,007		1,158
EyeSouth Eye Care Holdco LLC		959		1,279
Urology Management Holdings, Inc.		863		863
High Street Buyer, Inc.		631		631
CC SAG Holdings Corp. (Spectrum Automotive)		548		548
TAUC Management, LLC		294		294
Shoes for Crews Global, LLC		284		284
All States Ag Parts, LLC		257		331
Foundation Consumer Brands, LLC		—		3,009
Kaseya, Inc.		—		1,917
Total Commitments	$	268,648	$	234,554

* The Company controls the funding of these commitments and may cancel them at its discretion. 

The credit agreements governing the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of March 31, 2025 and December 31,

36

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

2024, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.

From time to time, the Company may become a party to certain legal proceedings incidental to the normal course of its business. As of March 31, 2025 and December 31, 2024, management is not aware of any material pending or threatened litigation that would require accounting recognition or financial statement disclosure.

Note 10. Capital Share Transactions

As of March 31, 2025 and March 31, 2024, 200,000,000 shares of $0.01 par value capital stock were authorized.

On February 28, 2025, the Company entered into an equity distribution agreement (the “Equity Distribution Agreement”) by and among the Company, the Investment Adviser and the Administrator, on the one hand, and Raymond James & Associates, Inc., Citizens JMP Securities, LLC and Jefferies LLC, as placement agents thereunder (collectively, the “Agents”), on the other hand. Under the Equity Distribution Agreement, the Company may, but has no obligation to, issue and sell up to $150,000 in aggregate amount of shares of its common stock from time to time through the Agents, or to them, as principal for their own account.

For the three months ended March 31, 2025, the Company sold no shares of common stock under the Equity Distribution Agreement. As of March 31, 2025, shares representing $150,000 of the Company’s common stock remain available for issuance and sale under the Equity Distribution Agreement.

Transactions in capital stock were as follows for the periods presented:

	Shares				Amount
	Three months ended March 31, 2025		Three months ended March 31, 2024		Three months ended March 31, 2025		Three months ended March 31, 2024
Share activity		—		—	$	—	$	—

Note 11. SLR Credit Solutions

On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions, f/k/a Crystal Financial LLC (“SLR Credit”). The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of March 31, 2025, total commitments to the revolving credit facility were $300,000.

As of March 31, 2025, SLR Credit had 28 funded commitments to 22 different issuers with total funded loans of approximately $294,983 on total assets of $362,769. As of December 31, 2024, SLR Credit had 27 funded commitments to 22 different issuers with total funded loans of approximately $317,565 on total assets of $364,258. As of March 31, 2025 and December 31, 2024, the largest loan outstanding totaled $27,691 and $27,879, respectively. For the same periods, the average exposure per issuer was $13,408 and $14,435, respectively. SLR Credit’s credit facility, which is non-recourse to the Company, had approximately $150,243 and $149,997 of borrowings outstanding at March 31, 2025 and December 31, 2024, respectively. For the three months ended March 31, 2025 and 2024, SLR Credit had net income of $5,200 and $5,719, respectively, on gross income of $10,056 and $13,056, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions.

Note 12. SLR Equipment Finance

On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance

37

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

company that provides senior secured loans and leases primarily to U.S.-based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. On January 31, 2024, SLR Equipment entered into a $225,000 senior secured credit facility with a maturity date of January 31, 2027. On March 1, 2024, the credit facility was expanded to $350,000 of commitments.

As of March 31, 2025, SLR Equipment had 503 funded equipment-backed leases and loans to 282 different customers with a total net investment in leases and loans of approximately $318,542 on total assets of $355,569. As of December 31, 2024, SLR Equipment had 398 funded equipment-backed leases and loans to 217 different customers with a total net investment in leases and loans of approximately $324,939 on total assets of $366,258. As of March 31, 2025 and December 31, 2024, the largest position outstanding totaled $18,825 and $17,883, respectively. For the same periods, the average exposure per customer was $1,130 and $1,497, respectively. SLR Equipment’s credit facility, which is non-recourse to the Company, had approximately $250,975 and $260,974 of borrowings outstanding at March 31, 2025 and December 31, 2024, respectively. For the three months ended March 31, 2025 and 2024, SLR Equipment had net loss of $1,917 and $1,956, respectively, on gross income of $6,655 and $4,170, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions.

Note 13. Kingsbridge Holdings, LLC

On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual-focused independent mid-ticket lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 of KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owned 87.5% of KBHT’s equity and the KBH management team owned the remaining 12.5% of KBHT’s equity. On March 13, 2024, as per the terms of the original purchase agreement, the Company acquired 3.125% of KBHT’s equity from the KBH management team. On March 11, 2025, as per the terms of the original purchase agreement, the Company acquired an additional 3.125% of KBHT’s equity from the KBH management team. Effective with these purchases, the Company owns 93.75% of KBHT’s equity and the KBH management team owns the remaining 6.25%.

As of March 31, 2025 and December 31, 2024, KBHT had total assets of $882,740 and $920,072, respectively. For the same periods, debt recourse to KBHT totaled $267,669 and $271,584, respectively, and non-recourse debt totaled $411,000 and $421,587, respectively. None of the debt is recourse to the Company. For the three months ended March 31, 2025 and 2024, KBHT had net income of $3,364 and $1,928, respectively, on gross income of $97,942 and $80,008, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.

Note 14. SLR Healthcare ABL

SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”), on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and mid-sized companies operating in the healthcare industry. SUNS’s initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare co-invested in the transaction and continues to lead SLR Healthcare. As of March 31, 2025, SLR Healthcare’s management team and the Company owned approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022. Effective upon an amendment dated September 19, 2024, SLR Healthcare has a $160,000 non-recourse credit facility, which is expandable to $200,000 under its accordion facility. The maturity date of this facility is March 31, 2026.

SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of March 31, 2025, the portfolio totaled approximately $288,250 of commitments with a total net investment in loans of $143,082 on total assets of $151,380. As of December 31, 2024, the portfolio totaled approximately $288,250 of commitments with a total net investment in loans of $130,207 on total assets of $138,494. At March 31, 2025, the portfolio consisted of 48 issuers with an average balance of approximately $2,981 versus 47 issuers with an average balance of approximately $2,770 at December 31, 2024. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured, cash-pay loans. SLR

38

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

Healthcare’s credit facility, which is non-recourse to us, had approximately $117,000 and $99,600 of borrowings outstanding at March 31, 2025 and December 31, 2024, respectively. For the three months ended March 31, 2025 and 2024, SLR Healthcare had net income of $1,431 and $1,318, respectively, on gross income of $5,304 and $4,791, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions.

Note 15. SLR Business Credit

SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based small-to-medium-sized businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and medium-sized businesses. As part of this transaction, SUNS’s 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022. On September 27, 2024, NMC acquired an asset-based factoring portfolio and operations from Webster Bank, N.A.’s Commercial Services Division. The transaction purchase price of approximately $127,000 was funded with $30,000 of equity from the Company and the remaining $97,000 from borrowings on NMC’s credit facility.

SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of March 31, 2025, the portfolio totaled approximately $886,108 of commitments, of which, on a net basis, approximately $526,351 were funded, on total assets of $565,505. As of December 31, 2024, the portfolio totaled approximately $857,953 of commitments, of which $488,402 were funded, on total assets of $527,077. At March 31, 2025, the portfolio consisted of 185 issuers with an average balance of approximately $2,845 versus 188 issuers with an average balance of approximately $2,598 at December 31, 2024. NMC has a senior credit facility with a bank lending group for $325,307 which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is non-recourse to us, had approximately $279,787 and $231,034 of borrowings outstanding at March 31, 2025 and December 31, 2024, respectively. For the three months ended March 31, 2025 and 2024, SLR Business Credit had net income of $2,551 and $3,181 respectively, on gross income of $12,928 and $11,168, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.

Note 16. Stock Repurchase Program

On May 7, 2024, our Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule 10b-18 of the Securities Exchange Act of 1934, as amended, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 7, 2025 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. There were no share repurchases during the three months ended March 31, 2025 or for the fiscal year ended December 31, 2024.

39

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

Note 17. SLR Senior Lending Program LLC

On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.

On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP, as servicer, and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower, entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. On October 20, 2023, the SSLP Facility was expanded to $150,000. Effective with an amendment on March 25, 2024, the SSLP Facility is scheduled to mature on December 12, 2028 and generally bears interest at a rate of SOFR plus 2.90%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At March 31, 2025 and December 31, 2024, borrowings outstanding on the SSLP Facility totaled $96,600 and $96,600, respectively.

As of March 31, 2025 and December 31, 2024, the Company and the Investor had contributed combined equity capital in the amount of $95,750 and $95,750, respectively. As of March 31, 2025 and December 31, 2024, the Company and the Investor’s combined remaining commitments to SSLP totaled $4,250 and $4,250, respectively. The Company and the Investor control the funding of SSLP, and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor.

As of March 31, 2025 and December 31, 2024, SSLP had total assets of $196,235 and $197,461, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 31 and 32 different borrowers, respectively. For the three months ended March 31, 2025, SSLP invested $6,588 in 6 portfolio companies. Investments prepaid totaled $19,918 for the three months ended March 31, 2025. For the three months ended March 31, 2024, SSLP invested $29,758 in 11 portfolio companies. Investments prepaid totaled $771 for the three months ended March 31, 2024.

40

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

SSLP Portfolio as of March 31, 2025

Description	Industry	Spread Above Index(1)	Floor			Interest Rate(2)			Maturity Date	Par Amount		Cost		Fair Value(3)
Accession Risk Management Group, Inc.	Insurance	S+475		0.75	%		9.04	%	11/2029	$	6,870	$	6,848	$	6,870
Aegis Toxicology Sciences Corporation (4)	Health Care Providers & Services	S+550		1.00	%		10.06	%	5/2025		2,881		2,881		2,881
Alkeme Intermediary Holdings, LLC (4)	Insurance	S+525		1.00	%		9.55	%	10/2026		5,970		5,862		5,970
All States Ag Parts, LLC (4)	Trading Companies & Distributors	S+650		1.00	%		11.06	%	9/2026		2,084		2,084		2,084
BayMark Health Services, Inc. (4)	Health Care Providers & Services	S+500		1.00	%		9.56	%	6/2027		3,982		3,982		3,982
CC SAG Holdings Corp. (4)	Diversified Consumer Services	S+525		0.75	%		9.57	%	6/2028		8,854		8,854		8,854
Crewline Buyer, Inc.	IT Services	S+675		1.00	%		11.07	%	11/2030		5,084		4,970		5,084
CVAUSA Management, LLC (4)	Health Care Providers & Services	S+525		1.00	%		9.57	%	5/2029		8,750		8,517		8,750
Erie Construction Mid-west, LLC	Building Products	S+475		1.00	%		9.19	%	7/2027		7,886		7,886		7,886
Exactcare Parent, Inc.	Health Care Providers & Services	S+550		1.00	%		9.80	%	11/2029		3,195		3,120		3,195
Eyesouth Eye Care Holdco LLC (4)	Health Care Providers & Services	S+550		1.00	%		9.92	%	10/2029		2,639		2,592		2,639
Fertility (ITC) Investment Holdco, LLC (4)	Health Care Providers & Services	S+650		1.00	%		10.74	%	1/2029		5,880		5,750		5,880
Foundation Consumer Brands, LLC	Personal Care Products	S+500		1.00	%		9.44	%	2/2029		7,929		7,929		7,929
High Street Buyer, Inc.	Insurance	S+525		0.75	%		9.55	%	4/2028		7,507		7,507		7,507
iCIMS, Inc.(4)	Software	S+575		0.75	%		10.04	%	8/2028		3,195		3,158		3,195
Kid Distro Holdings, LLC	Software	S+475		1.00	%		9.19	%	10/2029		8,825		8,825		8,825
Legacy Service Partners, LLC	Diversified Consumer Services	S+525		1.00	%		9.70	%	1/2029		2,789		2,729		2,789
Maxor Acquisition, Inc.(4)	Health Care Providers & Services	S+600		1.00	%		10.42	%	3/2029		7,012		6,858		7,012
Medrina, LLC	Health Care Providers & Services	S+600		1.00	%		10.25	%	10/2029		2,779		2,719		2,779
ONS MSO, LLC(4)	Health Care Providers & Services	S+625		1.00	%		10.54	%	7/2026		5,819		5,738		5,819
Plastic Management, LLC(4)	Health Care Providers & Services	S+500		1.00	%		9.30	%	8/2027		5,565		5,449		5,565
RQM+ Corp.(4)	Life Sciences Tools & Services	S+675		1.00	%		11.31	%	8/2029		5,949		5,949		5,711
RxSense Holdings LLC(4)	Diversified Consumer Services	S+500		1.00	%		9.39	%	3/2026		8,852		8,852		8,852
SunMed Group Holdings, LLC(4)	Health Care Equipment & Supplies	S+550		0.75	%		9.89	%	6/2028		8,833		8,833		8,833
The Townsend Company, LLC(4)	Commercial Services & Supplies	S+500		1.00	%		9.32	%	8/2030		4,281		4,189		4,241
Tilley Distribution, Inc.(4)	Trading Companies & Distributors	S+600		1.00	%		10.45	%	12/2026		5,592		5,592		5,480
United Digestive MSO Parent, LLC(4)	Health Care Providers & Services	S+575		1.00	%		10.05	%	3/2029		3,620		3,532		3,620
Urology Management Holdings, Inc.(4)	Health Care Providers & Services	S+550		1.00	%		9.80	%	6/2027		4,102		4,032		4,102
UVP Management, LLC(4)	Health Care Providers & Services	S+625		1.00	%		10.70	%	9/2025		4,846		4,810		4,846
WCI-BXC Purchaser, LLC	Distributors	S+625		1.00	%		10.55	%	11/2030		2,868		2,805		2,868
Western Veterinary Partners LLC(4)	Diversified Consumer Services	S+500		1.00	%		9.30	%	10/2027		1,585		1,562		1,585
												$	164,414	$	165,633

(1)Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.

(2)Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment, we have provided the current interest rate in effect as of March 31, 2025.

(3)Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4)The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

41

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

SSLP Portfolio as of December 31, 2024

Description	Industry	Spread Above Index(1)	Floor			Interest Rate(2)			Maturity Date	Par Amount		Cost		Fair Value(3)
Accession Risk Management Group, Inc.	Insurance	S+475		0.75	%		9.08	%	11/2029	$	6,888	$	6,865	$	6,888
Aegis Toxicology Sciences Corporation (4)	Health Care Providers & Services	S+550		1.00	%		10.28	%	5/2025		2,895		2,895		2,895
Alkeme Intermediary Holdings, LLC (4)	Insurance	S+575		1.00	%		10.08	%	10/2026		5,984		5,861		5,984
All States Ag Parts, LLC (4)	Trading Companies & Distributors	S+600		1.00	%		10.59	%	9/2026		2,111		2,111		2,111
BayMark Health Services, Inc. (4)	Health Care Providers & Services	S+500		1.00	%		9.59	%	6/2027		3,992		3,992		3,992
CC SAG Holdings Corp. (4)	Diversified Consumer Services	S+525		0.75	%		9.58	%	6/2028		8,877		8,877		8,877
Crewline Buyer, Inc.	IT Services	S+675		1.00	%		11.11	%	11/2030		5,084		4,966		5,084
CVAUSA Management, LLC (4)	Health Care Providers & Services	S+650		1.00	%		10.84	%	5/2029		5,357		5,220		5,357
Erie Construction Mid-west, LLC	Building Products	S+475		1.00	%		10.09	%	7/2027		8,000		8,000		8,000
Exactcare Parent, Inc.	Health Care Providers & Services	S+550		1.00	%		10.03	%	11/2029		3,203		3,125		3,203
Eyesouth Eye Care Holdco LLC (4)	Health Care Providers & Services	S+550		1.00	%		10.15	%	10/2029		2,646		2,596		2,646
Fertility (ITC) Investment Holdco, LLC (4)	Health Care Providers & Services	S+650		1.00	%		11.74	%	1/2029		5,895		5,757		5,895
Foundation Consumer Brands, LLC (4)	Personal Products	S+625		1.00	%		10.89	%	2/2027		8,102		8,102		8,102
High Street Buyer, Inc.	Insurance	S+525		0.75	%		9.58	%	4/2028		7,527		7,527		7,527
iCIMS, Inc.(4)	Software	S+575		0.75	%		10.38	%	8/2028		3,195		3,158		3,195
Kaseya, Inc.(4)	Software	S+550		0.75	%		10.75	%	6/2029		9,127		9,127		9,127
Kid Distro Holdings, LLC	Software	S+475		1.00	%		9.49	%	10/2029		8,848		8,848		8,848
Legacy Service Partners, LLC	Diversified Consumer Services	S+525		1.00	%		9.73	%	1/2029		2,796		2,733		2,796
Maxor Acquisition, Inc.(4)	Health Care Providers & Services	S+600		1.00	%		10.46	%	3/2029		6,058		5,906		6,058
Medrina, LLC	Health Care Providers & Services	S+600		1.00	%		10.44	%	10/2029		2,386		2,333		2,386
ONS MSO, LLC(4)	Health Care Providers & Services	S+625		1.00	%		10.84	%	7/2026		5,833		5,738		5,833
Plastic Management, LLC(4)	Health Care Providers & Services	S+500		1.00	%		9.43	%	8/2027		5,579		5,453		5,579
Retina Midco, Inc.(4)	Health Care Providers & Services	S+575		1.00	%		10.35	%	1/2026		9,918		9,793		10,116
RQM+ Corp.(4)	Life Sciences Tools & Services	S+675		1.00	%		11.34	%	8/2029		5,895		5,895		5,659
RxSense Holdings LLC(4)	Diversified Consumer Services	S+500		1.00	%		9.69	%	3/2026		8,875		8,875		8,875
SunMed Group Holdings, LLC(4)	Health Care Equipment & Supplies	S+550		0.75	%		10.19	%	6/2028		8,856		8,856		8,856
The Townsend Company, LLC(4)	Commercial Services & Supplies	S+500		1.00	%		9.36	%	8/2030		4,117		4,026		4,078
Tilley Distribution, Inc.(4)	Trading Companies & Distributors	S+600		1.00	%		10.48	%	12/2026		5,607		5,607		5,495
United Digestive MSO Parent, LLC(4)	Health Care Providers & Services	S+575		1.00	%		10.08	%	3/2029		3,433		3,346		3,433
Urology Management Holdings, Inc.(4)	Health Care Providers & Services	S+550		1.00	%		9.83	%	6/2027		4,112		4,035		4,112
UVP Management, LLC(4)	Health Care Providers & Services	S+625		1.00	%		10.73	%	9/2025		4,858		4,803		4,858
WCI-BXC Purchaser, LLC	Distributors	S+625		1.00	%		10.78	%	11/2030		2,875		2,810		2,875
												$	177,236	$	178,740

(1)Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.

(2)Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment, we have provided the current interest rate in effect as of December 31, 2024.

(3)Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4)The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

42

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

Below is certain summarized financial information for SSLP as of March 31, 2025 and December 31, 2024 and for the three months ended March 31, 2025 and March 31, 2024:

	March 31, 2025		December 31, 2024
Selected Balance Sheet Information for SSLP:
Investments at fair value (cost $164,414 and $177,236,    respectively)	$	165,633	$	178,740
Cash and other assets		30,602		18,721
Total assets	$	196,235	$	197,461
Debt outstanding ($96,600 and $96,600 face amounts,    respectively, reported net of unamortized debt issuance    costs of $1,446 and $1,572, respectively)	$	95,154	$	95,028
Distributions payable		3,395		3,381
Interest payable and other credit facility related expenses		465		472
Accrued expenses and other payables		345		398
Total liabilities	$	99,359	$	99,279
Members’ equity	$	96,876	$	98,182
Total liabilities and members’ equity	$	196,235	$	197,461

	Three months ended
	March 31, 2025			March 31, 2024
Selected Income Statement Information for SSLP:
Interest income	$	4,469		$	5,969
Service fees*		105			125
Interest and other credit facility expenses		2,242			2,718
Other general and administrative expenses		71			44
Total expenses		2,418			2,887
Net investment income	$	2,051		$	3,082
Realized gain on investments		323			—
Net change in unrealized gain (loss) on investments		(285	)		509
Net realized and unrealized gain (loss) on investments	$	38		$	509
Net income	$	2,089		$	3,591

* Service fees are included within the Company’s Consolidated Statements of Operations as other income.

Note 18. Segment Reporting

The Company operates as a single reporting segment and derives its revenue from providing comprehensive financing solutions primarily to middle market borrowers in the United States through direct cash flow lending or specialty finance instruments. The Company has identified its co-CEOs as the CODM. The CODM reviews all significant segment expenses on the Consolidated Statements of Operations and uses net investment income to evaluate the performance of the Company and to determine distributions. Additionally, the CODM uses net asset value per share (see Note 4) to determine capital adequacy of the Company. All metrics are used to ultimately allocate resources to the Company as needed.

The accounting policies used to measure the revenue and expenses of the segment are the same as those described in Note 2.

Note 19. Subsequent Events

The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.

43

SLR INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2025

(in thousands, except share and per share amounts)

On May 7, 2025, the Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of the Company’s outstanding shares of common stock. Under the repurchase program, the Company may, but is not obligated to, repurchase shares of the Company’s outstanding common stock in the open market from time to time provided that the Company complies with the Company’s code of ethics and the guidelines specified in Rule 10b-18 of the 1934 Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by the Board, the Company expects the repurchase program to be in place until the earlier of May 7, 2026 or until $50,000 of the Company’s outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that the Company will engage in any repurchases.

On May 7, 2025, the Board declared a quarterly distribution of $0.41 per share payable on June 27, 2025 to holders of record as of June 13, 2025.

44

Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors

SLR Investment Corp.:

Results of Review of Interim Financial Information

We have reviewed the consolidated statement of assets and liabilities of SLR Investment Corp. (and subsidiaries) (the Company), including the consolidated schedule of investments, as of March 31, 2025, the related consolidated statements of operations, changes in net assets and cash flows for the three-month periods ended March 31, 2025 and 2024, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statement of assets and liabilities, including the consolidated schedule of investments, of the Company as of December 31, 2024, and the related consolidated statements of operations, changes in net assets, and cash flows for the year then ended (not presented herein); and in our report dated February 25, 2025, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated statement of assets and liabilities, including the consolidated schedule of investments, as of December 31, 2024, is fairly stated, in all material respects, in relation to the consolidated statement of assets and liabilities, including the consolidated schedule of investments, from which it has been derived.

Basis for Review Results

This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ KPMG LLP

New York, New York

May 7, 2025

45

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The information contained in this section should be read in conjunction with our consolidated financial statements and notes thereto appearing elsewhere in this report.

Some of the statements in this report constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained herein involve risks and uncertainties, including statements as to:

•our future operating results, including our ability to achieve objectives;

•our business prospects and the prospects of our portfolio companies;

•the impact of investments that we expect to make;

•our contractual arrangements and relationships with third parties;

•the dependence of our future success on the general economy and its impact on the industries in which we invest;

•the impact of any protracted decline in the liquidity of credit markets on our business;

•changes in U.S. tariff and import/export regulations;

•the ability of our portfolio companies to achieve their objectives;

•the valuation of our investments in portfolio companies, particularly those having no liquid trading market;

•market conditions and our ability to access alternative debt markets and additional debt and equity capital;

•our expected financings and investments;

•the adequacy of our cash resources and working capital;

•the timing of cash flows, if any, from the operations of our portfolio companies;

•the ability of SLR Capital Partners, LLC (the “Investment Adviser”) to locate suitable investments for us and to monitor and administer our investments;

•the ability of the Investment Adviser to attract and retain highly talented professionals;

•the ability of the Investment Adviser to adequately allocate investment opportunities among the Company and the Investment Adviser’s other advisory clients;

•any conflicts of interest posed by the structure of the management fee and incentive fee to be paid to the Investment Adviser;

•changes in political, economic or industry conditions, relations between the United States, Russia, Ukraine and other nations, the interest rate environment, certain regional bank failures or conditions affecting the financial and capital markets;

•the escalating conflict in the Middle East;

•changes in the general economy, slowing economy, rising inflation, risk of recession and risks in respect of a failure to increase the U.S. debt ceiling; and

•our ability to anticipate and identify evolving market expectations with respect to environmental, social and governance matters, including the environmental impacts of our portfolio companies’ supply chains and operations.

These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

•an economic downturn could impair our portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of our investments in such portfolio companies;

•a contraction of available credit and/or an inability to access the equity markets could impair our lending and investment activities;

46

•interest rate volatility could adversely affect our results, particularly because we use leverage as part of our investment strategy;

•currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to the extent that we receive payments denominated in foreign currency rather than U.S. dollars; and

•the risks, uncertainties and other factors we identify in Item 1A. — Risk Factors contained in our Annual Report on Form 10-K for the year ended December 31, 2024, elsewhere in this Quarterly Report on Form 10-Q and in our other filings with the Securities and Exchange Commission (the “SEC”).

We generally use words such as “anticipates,” “believes,” “expects,” “intends” and similar expressions to identify forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements for any reason, including any factors set forth in “Risk Factors” and elsewhere in this report.

We have based the forward-looking statements included in this report on information available to us on the date of this report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including any annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

Overview

SLR Investment Corp. (the “Company,” “SLRC,” “we” or “our”), a Maryland corporation formed in November 2007, is an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S federal income tax purposes, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

On February 9, 2010, we priced our initial public offering, selling 5.68 million shares of our common stock. Concurrent with our initial public offering, Michael S. Gross, our Chairman, Co-Chief Executive Officer and President, and Bruce Spohler, our Co-Chief Executive Officer, Chief Operating Officer and board member, collectively purchased an additional 0.6 million shares of our common stock through a private placement transaction exempt from registration under the Securities Act of 1933, as amended.

We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. Our investment objective is to generate both current income and capital appreciation through debt and equity investments. We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. Our business is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our investments generally range between $5 million and $100 million each, although we expect that this investment size will vary proportionately with the size of our capital base and/or with strategic initiatives. Our investment activities are managed by the Investment Adviser and supervised by our board of directors (the “Board”), a majority of whom are non-interested, as such term is defined in the 1940 Act. SLR Capital Management, LLC (the “Administrator”) provides the administrative services necessary for us to operate.

In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to enhance our overall returns. These investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States.

Recent Developments

On May 7, 2025, the Board authorized an extension of a program for the purpose of repurchasing up to $50 million of the Company’s outstanding shares of common stock. Under the repurchase program, the Company may, but is not obligated to, repurchase shares of the Company’s outstanding common stock in the open market from time to time provided that the Company complies with the Company’s code of ethics and the guidelines specified in Rule 10b-18 of the Securities Exchange Act of 1934, as amended (the “1934 Act”), including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by the Board, the Company expects the repurchase program to be in place until the earlier of May 7, 2026 or until $50 million of the Company’s outstanding shares of common stock

47

have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that the Company will engage in any repurchases.

On May 7, 2025, the Board declared a quarterly distribution of $0.41 per share payable on June 27, 2025 to holders of record as of June 13, 2025.

Investments

Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity for such companies, the general economic environment and the competitive environment for the types of investments we make. As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” The definition of “eligible portfolio company” includes certain public companies that do not have any securities listed on a national securities exchange and companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.

Revenue

We generate revenue primarily in the form of interest and dividend income from the securities we hold and capital gains, if any, on investment securities that we may sell. Our debt investments generally have a stated term of three to seven years and typically bear interest at a floating rate usually determined on the basis of a benchmark Secured Overnight Financing Rate (“SOFR”), commercial paper rate, or the prime rate. Interest on our debt investments is generally payable monthly or quarterly but may be bi-monthly or semi-annually. In addition, our investments may provide payment-in-kind (“PIK”) income. Such amounts of accrued PIK income are added to the cost of the investment on the respective capitalization dates and generally become due at maturity of the investment or upon the investment being called by the issuer. We may also generate revenue in the form of commitment, origination, structuring fees, fees for providing managerial assistance and, if applicable, consulting fees, etc.

Expenses

All investment professionals of the Investment Adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by the Investment Adviser. We bear all other costs and expenses of our operations and transactions, including (without limitation):

•the cost of our organization and public offerings;

•the cost of calculating our net asset value, including the cost of any third-party valuation services;

•the cost of effecting sales and repurchases of our shares and other securities;

•interest payable on debt, if any, to finance our investments;

•fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees;

•transfer agent and custodial fees;

•fees and expenses associated with marketing efforts;

•federal and state registration fees, any stock exchange listing fees;

•federal, state and local taxes;

•independent directors’ fees and expenses;

•brokerage commissions;

•fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums;

•direct costs and expenses of administration, including printing, mailing, long distance telephone and staff;

•fees and expenses associated with independent audits and outside legal costs;

48

•costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and

•all other expenses incurred by either the Administrator or us in connection with administering our business, including payments under the Administration Agreement (as defined below) that will be based upon our allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs.

We expect our general and administrative operating expenses related to our ongoing operations to increase moderately in dollar terms. During periods of asset growth, we generally expect our general and administrative operating expenses to decline as a percentage of our total assets and increase during periods of asset declines. Incentive fees, interest expense and costs relating to future offerings of securities, among others, may also increase or reduce overall operating expenses based on portfolio performance, interest rate benchmarks and offerings of our securities relative to comparative periods, among other factors.

Portfolio and Investment Activity

During the three months ended March 31, 2025, we invested approximately $193.5 million across 30 portfolio companies. This compares to investing approximately $100.2 million in 24 portfolio companies during the three months ended March 31, 2024. Investments sold, prepaid or repaid during the three months ended March 31, 2025 totaled approximately $196.9 million versus approximately $131.0 million for the three months ended March 31, 2024.

At March 31, 2025, our portfolio consisted of 118 portfolio companies and was invested 28.6% in cash flow senior secured loans, 38.9% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 21.6% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 10.9% in life science investments, in each case, measured at fair value, versus 145 portfolio companies invested 33.3% in cash flow senior secured loans, 28.2% in asset-based senior secured loans / SLR Credit / SLR Healthcare ABL / SLR Business Credit, 22.6% in equipment senior secured financings / SLR Equipment / KBH, and 15.9% in life science investments, in each case, measured at fair value, at March 31, 2024.

At March 31, 2025, 81.5%, or $1.61 billion, of our income producing investment portfolio* was floating rate and 18.5%, or $364.4 million, was fixed rate, measured at fair value. At March 31, 2024, 81.3%, or $1.71 billion, of our income producing investment portfolio* was floating rate and 18.7%, or $393.6 million, was fixed rate, measured at fair value. As of March 31, 2025 and 2024, we had one and two issuers, respectively, on non-accrual status.

* We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio.

SLR Credit Solutions

On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275 million in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions, f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400 million at November 30, 2012 and a $275 million committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5.7 million. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of March 31, 2025, total commitments to the revolving credit facility were $300 million.

As of March 31, 2025, SLR Credit had 28 funded commitments to 22 different issuers with total funded loans of approximately $295.0 million on total assets of $362.8 million. As of December 31, 2024, SLR Credit had 27 funded commitments to 22 different issuers with total funded loans of approximately $317.6 million on total assets of $364.3 million. As of March 31, 2025 and December 31, 2024, the largest loan outstanding totaled $27.7 million and $27.9 million, respectively. For the same periods, the average exposure per issuer was $13.4 million and $14.4 million, respectively. SLR Credit’s credit facility, which is non-recourse to the Company, had approximately $150.2 million and $150.0 million of borrowings outstanding at March 31, 2025 and December 31, 2024, respectively. For the three months ended March 31, 2025 and 2024, SLR Credit had net income of $5.2 million and $5.7 million, respectively, on gross income of $10.1 million and $13.1 million, respectively. Due to timing and non-cash items, there may be material differences between U.S. generally accepted accounting principles (“GAAP”) net income and cash available for

49

distributions. As such, and subject to fluctuations in SLR Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Credit will be able to maintain consistent dividend payments to us.

SLR Equipment Finance

On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance. SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209.9 million in cash to effect the transaction, of which $145.0 million was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64.9 million was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. On January 31, 2024, SLR Equipment entered into a $225 million senior secured credit facility with a maturity date of January 31, 2027. On March 1, 2024, the credit facility was expanded to $350 million of commitments.

As of March 31, 2025, SLR Equipment had 503 funded equipment-backed leases and loans to 282 different customers with a total net investment in leases and loans of approximately $318.5 million on total assets of $355.6 million. As of December 31, 2024, SLR Equipment had 398 funded equipment-backed leases and loans to 217 different customers with a total net investment in leases and loans of approximately $324.9 million on total assets of $366.3 million. As of March 31, 2025 and December 31, 2024, the largest position outstanding totaled $18.8 million and $17.9 million, respectively. For the same periods, the average exposure per customer was $1.1 million and $1.5 million, respectively. SLR Equipment’s credit facility, which is non-recourse to the Company, had approximately $251.0 million and $261.0 million of borrowings outstanding at March 31, 2025 and December 31, 2024, respectively. For the three months ended March 31, 2025 and 2024, SLR Equipment had net loss of $1.9 million and $2.0 million, respectively, on gross income of $6.7 million and $4.2 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Equipment’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Equipment will be able to maintain consistent dividend payments to us.

Kingsbridge Holdings, LLC

On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent mid-ticket lessor of equipment primarily to U.S. investment grade companies. The Company invested $216.6 million to effect the transaction, of which $136.6 million was invested to acquire 87.5% of KBHT’s equity and $80.0 million of KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT’s equity and the KBH management team owns the remaining 12.5% of KBHT’s equity. On March 13, 2024, as per the terms of the original purchase agreement, the Company acquired 3.125% of KBHT’s equity from the KBH management team. On March 11, 2025, as per the terms of the original purchase agreement, the Company acquired an additional 3.125% of KBHT’s equity from the KBH management team. Effective with these purchases, the Company owns 93.75% of KBHT’s equity and the KBH management team owns the remaining 6.25%.

As of March 31, 2025 and December 31, 2024, KBHT had total assets of $882.7 million and $920.1 million, respectively. For the same periods, debt recourse to KBHT totaled $267.7 million and $271.6 million, respectively, and non-recourse debt totaled $411.0 million and $421.6 million, respectively. None of the debt is recourse to the Company. For the three months ended March 31, 2025 and 2024, KBHT had net income of $3.4 million and $1.9 million, respectively, on gross income of $97.9 million and $80.0 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.

SLR Healthcare ABL

SLR Senior Investment Corp. (“SUNS”) acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and mid-sized companies operating in the healthcare industry. SUNS’s initial investment in SLR Healthcare ABL was approximately $32.8 million. The management team of SLR Healthcare co-invested in the transaction and continues to lead SLR Healthcare. As of March 31, 2025, SLR Healthcare’s management team and the Company owned approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers (as defined in Note 1 to the Company’s Consolidated Financial Statements) on April 1, 2022. Effective with an

50

amendment dated September 19, 2024, SLR Healthcare has a $160 million non-recourse credit facility, which is expandable to $200 million under its accordion facility. The maturity date of this facility is March 31, 2026.

SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of March 31, 2025, the portfolio totaled approximately $288.3 million of commitments with a total net investment in loans of $143.1 million on total assets of $151.4 million. As of December 31, 2024, the portfolio totaled approximately $288.3 million of commitments with a total net investment in loans of $130.2 million on total assets of $138.5 million. At March 31, 2025, the portfolio consisted of 48 issuers with an average balance of approximately $3.0 million versus 47 issuers with an average balance of approximately $2.8 million at December 31, 2024. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured, cash-pay loans. SLR Healthcare’s credit facility, which is non-recourse to us, had approximately $117.0 million and $99.6 million of borrowings outstanding at March 31, 2025 and December 31, 2024, respectively. For the three months ended March 31, 2025 and 2024, SLR Healthcare had net income of $1.4 million and $1.3 million, respectively, on gross income of $5.3 million and $4.8 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Healthcare’s funded commitments, the timing of originations, and the repayment of financings, the Company cannot guarantee that SLR Healthcare will be able to maintain consistent dividend payments to us.

SLR Business Credit

SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based small-to-medium-sized businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51.0 million to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and medium-sized businesses. As part of this transaction, SUNS’s 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15.5 million transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66.7 million was financed with equity from SUNS of $19.0 million and borrowings on NMC’s credit facility of $47.7 million. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022. On September 27, 2024, NMC acquired an asset-based factoring portfolio and operations from Webster Bank, N.A.’s Commercial Services Division. The transaction purchase price of approximately $127 million was funded with $30 million of equity from the Company and the remaining $97 million from borrowings on NMC’s credit facility.

SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of March 31, 2025, the portfolio totaled approximately $886.1 million of commitments, of which, on a net basis, approximately $526.4 million were funded, on total assets of $565.5 million. As of December 31, 2024, the portfolio totaled approximately $858.0 million of commitments, of which $488.4 million were funded, on total assets of $527.1 million. At March 31, 2025, the portfolio consisted of 185 issuers with an average balance of approximately $2.8 million versus 188 issuers with an average balance of approximately $2.6 million at December 31, 2024. NMC has a senior credit facility with a bank lending group for $325.3 million, which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is non-recourse to us, had approximately $279.8 million and $231.0 million of borrowings outstanding at March 31, 2025 and December 31, 2024, respectively. For the three months ended March 31, 2025 and 2024, SLR Business Credit had net income of $2.6 million and $3.2 million, respectively, on gross income of $12.9 million and $11.2 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.

SLR Senior Lending Program LLC

On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50 million, resulting in a total equity commitment of $100 million. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.

51

On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP, as servicer, and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower, entered into a $100 million senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. On October 20, 2023, the SSLP Facility was expanded to $150 million. Effective with an amendment on March 25, 2024, the SSLP Facility is scheduled to mature on December 12, 2028 and generally bears interest at a rate of SOFR plus 2.90%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At March 31, 2025 and December 31, 2024, borrowings outstanding on the SSLP Facility totaled $96.6 million and $96.6 million, respectively.

As of March 31, 2025 and December 31, 2024, the Company and the Investor had contributed combined equity capital in the amount of $95.75 million and $95.75 million, respectively. As of March 31, 2025 and December 31, 2024, the Company and the Investor’s combined remaining commitments to SSLP totaled $4.25 million and $4.25 million, respectively. The Company, along with the Investor, controls the funding of SSLP, and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor.

As of March 31, 2025 and December 31, 2024, SSLP had total assets of $196.2 million and $197.5 million, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 31 and 32 different borrowers, respectively. For the three months ended March 31, 2025, SSLP invested $6.6 million in 6 portfolio companies. Investments prepaid totaled $19.9 million for the three months ended March 31, 2025. For the three months ended March 31, 2024, SSLP invested $29.8 million in 11 portfolio companies. Investments prepaid totaled $0.8 million for the three months ended March 31, 2024.

52

SSLP Portfolio as of March 31, 2025 (dollar amounts in thousands)

Description	Industry	Spread Above Index(1)	Floor			Interest Rate(2)			Maturity Date	Par Amount		Cost		Fair Value(3)
Accession Risk Management Group, Inc.	Insurance	S+475		0.75	%		9.04	%	11/2029	$	6,870	$	6,848	$	6,870
Aegis Toxicology Sciences Corporation (4)	Health Care Providers & Services	S+550		1.00	%		10.06	%	5/2025		2,881		2,881		2,881
Alkeme Intermediary Holdings, LLC (4)	Insurance	S+525		1.00	%		9.55	%	10/2026		5,970		5,862		5,970
All States Ag Parts, LLC (4)	Trading Companies & Distributors	S+650		1.00	%		11.06	%	9/2026		2,084		2,084		2,084
BayMark Health Services, Inc. (4)	Health Care Providers & Services	S+500		1.00	%		9.56	%	6/2027		3,982		3,982		3,982
CC SAG Holdings Corp. (4)	Diversified Consumer Services	S+525		0.75	%		9.57	%	6/2028		8,854		8,854		8,854
Crewline Buyer, Inc.	IT Services	S+675		1.00	%		11.07	%	11/2030		5,084		4,970		5,084
CVAUSA Management, LLC (4)	Health Care Providers & Services	S+525		1.00	%		9.57	%	5/2029		8,750		8,517		8,750
Erie Construction Mid-west, LLC	Building Products	S+475		1.00	%		9.19	%	7/2027		7,886		7,886		7,886
Exactcare Parent, Inc.	Health Care Providers & Services	S+550		1.00	%		9.80	%	11/2029		3,195		3,120		3,195
Eyesouth Eye Care Holdco LLC (4)	Health Care Providers & Services	S+550		1.00	%		9.92	%	10/2029		2,639		2,592		2,639
Fertility (ITC) Investment Holdco, LLC (4)	Health Care Providers & Services	S+650		1.00	%		10.74	%	1/2029		5,880		5,750		5,880
Foundation Consumer Brands, LLC	Personal Care Products	S+500		1.00	%		9.44	%	2/2029		7,929		7,929		7,929
High Street Buyer, Inc.	Insurance	S+525		0.75	%		9.55	%	4/2028		7,507		7,507		7,507
iCIMS, Inc.(4)	Software	S+575		0.75	%		10.04	%	8/2028		3,195		3,158		3,195
Kid Distro Holdings, LLC	Software	S+475		1.00	%		9.19	%	10/2029		8,825		8,825		8,825
Legacy Service Partners, LLC	Diversified Consumer Services	S+525		1.00	%		9.70	%	1/2029		2,789		2,729		2,789
Maxor Acquisition, Inc.(4)	Health Care Providers & Services	S+600		1.00	%		10.42	%	3/2029		7,012		6,858		7,012
Medrina, LLC	Health Care Providers & Services	S+600		1.00	%		10.25	%	10/2029		2,779		2,719		2,779
ONS MSO, LLC(4)	Health Care Providers & Services	S+625		1.00	%		10.54	%	7/2026		5,819		5,738		5,819
Plastic Management, LLC(4)	Health Care Providers & Services	S+500		1.00	%		9.30	%	8/2027		5,565		5,449		5,565
RQM+ Corp.(4)	Life Sciences Tools & Services	S+675		1.00	%		11.31	%	8/2029		5,949		5,949		5,711
RxSense Holdings LLC(4)	Diversified Consumer Services	S+500		1.00	%		9.39	%	3/2026		8,852		8,852		8,852
SunMed Group Holdings, LLC(4)	Health Care Equipment & Supplies	S+550		0.75	%		9.89	%	6/2028		8,833		8,833		8,833
The Townsend Company, LLC(4)	Commercial Services & Supplies	S+500		1.00	%		9.32	%	8/2030		4,281		4,189		4,241
Tilley Distribution, Inc.(4)	Trading Companies & Distributors	S+600		1.00	%		10.45	%	12/2026		5,592		5,592		5,480
United Digestive MSO Parent, LLC(4)	Health Care Providers & Services	S+575		1.00	%		10.05	%	3/2029		3,620		3,532		3,620
Urology Management Holdings, Inc.(4)	Health Care Providers & Services	S+550		1.00	%		9.80	%	6/2027		4,102		4,032		4,102
UVP Management, LLC(4)	Health Care Providers & Services	S+625		1.00	%		10.70	%	9/2025		4,846		4,810		4,846
WCI-BXC Purchaser, LLC	Distributors	S+625		1.00	%		10.55	%	11/2030		2,868		2,805		2,868
Western Veterinary Partners LLC(4)	Diversified Consumer Services	S+500		1.00	%		9.30	%	10/2027		1,585		1,562		1,585
												$	164,414	$	165,633

(1)Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.

(2)Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment, we have provided the current interest rate in effect as of March 31, 2025.

(3)Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4)The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

53

SSLP Portfolio as of December 31, 2024 (dollar amounts in thousands)

Description	Industry	Spread Above Index(1)	Floor			Interest Rate(2)			Maturity Date	Par Amount		Cost		Fair Value(3)
Accession Risk Management Group, Inc.	Insurance	S+475		0.75	%		9.08	%	11/2029	$	6,888	$	6,865	$	6,888
Aegis Toxicology Sciences Corporation (4)	Health Care Providers & Services	S+550		1.00	%		10.28	%	5/2025		2,895		2,895		2,895
Alkeme Intermediary Holdings, LLC (4)	Insurance	S+575		1.00	%		10.08	%	10/2026		5,984		5,861		5,984
All States Ag Parts, LLC (4)	Trading Companies & Distributors	S+600		1.00	%		10.59	%	9/2026		2,111		2,111		2,111
BayMark Health Services, Inc. (4)	Health Care Providers & Services	S+500		1.00	%		9.59	%	6/2027		3,992		3,992		3,992
CC SAG Holdings Corp. (4)	Diversified Consumer Services	S+525		0.75	%		9.58	%	6/2028		8,877		8,877		8,877
Crewline Buyer, Inc.	IT Services	S+675		1.00	%		11.11	%	11/2030		5,084		4,966		5,084
CVAUSA Management, LLC (4)	Health Care Providers & Services	S+650		1.00	%		10.84	%	5/2029		5,357		5,220		5,357
Erie Construction Mid-west, LLC	Building Products	S+475		1.00	%		10.09	%	7/2027		8,000		8,000		8,000
Exactcare Parent, Inc.	Health Care Providers & Services	S+550		1.00	%		10.03	%	11/2029		3,203		3,125		3,203
Eyesouth Eye Care Holdco LLC (4)	Health Care Providers & Services	S+550		1.00	%		10.15	%	10/2029		2,646		2,596		2,646
Fertility (ITC) Investment Holdco, LLC (4)	Health Care Providers & Services	S+650		1.00	%		11.74	%	1/2029		5,895		5,757		5,895
Foundation Consumer Brands, LLC (4)	Personal Products	S+625		1.00	%		10.89	%	2/2027		8,102		8,102		8,102
High Street Buyer, Inc.	Insurance	S+525		0.75	%		9.58	%	4/2028		7,527		7,527		7,527
iCIMS, Inc.(4)	Software	S+575		0.75	%		10.38	%	8/2028		3,195		3,158		3,195
Kaseya, Inc.(4)	Software	S+550		0.75	%		10.75	%	6/2029		9,127		9,127		9,127
Kid Distro Holdings, LLC	Software	S+475		1.00	%		9.49	%	10/2029		8,848		8,848		8,848
Legacy Service Partners, LLC	Diversified Consumer Services	S+525		1.00	%		9.73	%	1/2029		2,796		2,733		2,796
Maxor Acquisition, Inc.(4)	Health Care Providers & Services	S+600		1.00	%		10.46	%	3/2029		6,058		5,906		6,058
Medrina, LLC	Health Care Providers & Services	S+600		1.00	%		10.44	%	10/2029		2,386		2,333		2,386
ONS MSO, LLC(4)	Health Care Providers & Services	S+625		1.00	%		10.84	%	7/2026		5,833		5,738		5,833
Plastic Management, LLC(4)	Health Care Providers & Services	S+500		1.00	%		9.43	%	8/2027		5,579		5,453		5,579
Retina Midco, Inc.(4)	Health Care Providers & Services	S+575		1.00	%		10.35	%	1/2026		9,918		9,793		10,116
RQM+ Corp.(4)	Life Sciences Tools & Services	S+675		1.00	%		11.34	%	8/2029		5,895		5,895		5,659
RxSense Holdings LLC(4)	Diversified Consumer Services	S+500		1.00	%		9.69	%	3/2026		8,875		8,875		8,875
SunMed Group Holdings, LLC(4)	Health Care Equipment & Supplies	S+550		0.75	%		10.19	%	6/2028		8,856		8,856		8,856
The Townsend Company, LLC(4)	Commercial Services & Supplies	S+500		1.00	%		9.36	%	8/2030		4,117		4,026		4,078
Tilley Distribution, Inc.(4)	Trading Companies & Distributors	S+600		1.00	%		10.48	%	12/2026		5,607		5,607		5,495
United Digestive MSO Parent, LLC(4)	Health Care Providers & Services	S+575		1.00	%		10.08	%	3/2029		3,433		3,346		3,433
Urology Management Holdings, Inc.(4)	Health Care Providers & Services	S+550		1.00	%		9.83	%	6/2027		4,112		4,035		4,112
UVP Management, LLC(4)	Health Care Providers & Services	S+625		1.00	%		10.73	%	9/2025		4,858		4,803		4,858
WCI-BXC Purchaser, LLC	Distributors	S+625		1.00	%		10.78	%	11/2030		2,875		2,810		2,875
												$	177,236	$	178,740

(1)Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.

(2)Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment, we have provided the current interest rate in effect as of December 31, 2024.

(3)Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4)The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

Below is certain summarized financial information for SSLP as of March 31, 2025 and December 31, 2024 and for the three months ended March 31, 2025 and 2024:

	March 31, 2025		December 31, 2024
Selected Balance Sheet Information for SSLP (in thousands):
Investments at fair value (cost $164,414 and $177,236,    respectively)	$	165,633	$	178,740
Cash and other assets		30,602		18,721
Total assets	$	196,235	$	197,461
Debt outstanding ($96,600 and $96,600 face amounts,    respectively, reported net of unamortized debt issuance    costs of $1,446 and $1,572, respectively)	$	95,154	$	95,028
Distributions payable		3,395		3,381
Interest payable and other credit facility related expenses		465		472
Accrued expenses and other payables		345		398
Total liabilities	$	99,359	$	99,279
Members’ equity	$	96,876	$	98,182
Total liabilities and members’ equity	$	196,235	$	197,461

54

	Three months ended
	March 31, 2025			March 31, 2024
Selected Income Statement Information for SSLP (in thousands):
Interest income	$	4,469		$	5,969
Service fees*		105			125
Interest and other credit facility expenses		2,242			2,718
Other general and administrative expenses		71			44
Total expenses		2,418			2,887
Net investment income	$	2,051		$	3,082
Realized gain on investments		323			—
Net change in unrealized gain (loss) on investments		(285	)		509
Net realized and unrealized gain (loss) on investments	$	38		$	509
Net income	$	2,089		$	3,591

* Service fees are included within the Company’s Consolidated Statements of Operations as other income.

Critical Accounting Policies

The preparation of consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and revenues and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following items as critical accounting policies. Within the context of these critical accounting policies and disclosed subsequent events herein, we are not currently aware of any other reasonably likely events or circumstances that would result in materially different amounts being reported.

Valuation of Portfolio Investments

In December 2020, the SEC adopted Rule 2a-5 under the 1940 Act addressing fair valuation of fund investments. The rule sets forth requirements for good faith determinations of fair value, as well as for the performance of fair value determinations, including related oversight and reporting obligations. The rule also defines “readily available market quotations” for purposes of the definition of “value” under the 1940 Act, and the SEC noted that this definition will apply in all contexts under the 1940 Act. The Company complies with the Rule 2a-5 valuation requirements.

We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with GAAP and the 1940 Act. The Board will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule 2a-5 under the 1940 Act; and (6) maintain recordkeeping requirements under Rule 2a-5.

It is anticipated that in respect of many of the Company’s assets, readily available market quotations will not be obtainable and that such assets will be valued at fair value. A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation.

Our valuation procedures are set forth in more detail in Note 2(b) to the Company’s consolidated financial statements. Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our consolidated financial statements.

Revenue Recognition

The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Investments that are expected to pay regularly scheduled interest and/or dividends in cash are generally placed on non-accrual status when principal or interest/dividend cash payments are past due 30 days or more (90 days or more for equipment

55

financing) and/or when it is no longer probable that principal or interest/dividend cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest or dividends are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining interest or dividend obligations. Interest or dividend cash payments received on investments may be recognized as income or applied to principal depending upon management’s judgment. Some of our investments may have contractual PIK income. PIK income computed at the contractual rate, as applicable, is accrued and reflected as a receivable up to the capitalization date. PIK investments offer issuers the option at each payment date of making payments in cash or in additional securities. When additional securities are received, they typically have the same terms, including maturity dates and interest rates, as the original securities issued. On these payment dates, the Company capitalizes the accrued interest or dividends receivable (reflecting such amounts as the basis in the additional securities received). PIK generally becomes due at the maturity of the investment or upon the investment being called by the issuer. At the point the Company believes PIK is not expected to be realized, the PIK investment will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest or dividends is reversed from the related receivable through interest or dividend income, respectively. The Company does not reverse previously capitalized PIK income. Upon capitalization, PIK is subject to the fair value estimates associated with their related investments. PIK investments on non-accrual status are restored to accrual status if the Company again believes that PIK is expected to be realized. Loan origination fees, original issue discount, and market discounts are capitalized and amortized into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record prepayment premiums on loans and other investments as interest income when we receive such amounts. Capital structuring fees are recorded as other income when earned.

The typically higher yields and interest rates on PIK securities, to the extent we invested, reflect the payment deferral and increased credit risks associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the loan-to-value ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on non-cash accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the three months ended March 31, 2025 and 2024, capitalized PIK income totaled $1.7 million and $2.8 million, respectively.

Net Realized Gain or Loss and Net Change in Unrealized Gain or Loss

We generally measure realized gain or loss by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized origination or commitment fees and prepayment penalties. The net change in unrealized gain or loss reflects the change in portfolio investment values during the reporting period, including the reversal of previously recorded unrealized gain or loss, when gains or losses are realized. Gains or losses on investments are calculated by using the specific identification method.

Income Taxes

SLRC, a U.S. corporation, has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. In order to qualify for U.S. federal income taxation as a RIC, the Company is required, among other things, to timely distribute to its stockholders at least 90% of investment company taxable income, as defined by the Code, for each year. Depending on the level of taxable income earned in a given tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year distributions, the Company accrues an estimated excise tax, if any, on estimated excess taxable income.

Recent Accounting Pronouncements

The Company considers the applicability and impact of all accounting standard updates (“ASU”) issued by the Financial Accounting Standards Board. ASUs not listed were assessed and either determined to be not applicable or expected to have minimal impact on its consolidated financial statements.

56

RESULTS OF OPERATIONS

Results comparisons for the three months ended March 31, 2025 and March 31, 2024 are presented below:

Investment Income

For the three months ended March 31, 2025 and 2024, gross investment income totaled $53.2 million and $58.1 million, respectively. The decrease in gross investment income for the year over year three month periods was primarily due to a decrease in the size of the income-producing investment portfolio as well as a decrease in index rates. 

Expenses

Net expenses totaled $31.1 million and $34.2 million, respectively, for the three months ended March 31, 2025 and 2024, of which $13.0 million and $13.8 million, respectively, consisted of base management fees and performance-based incentive fees and $15.8 million and $18.2 million, respectively, consisted of interest and other credit facility expenses. Other general and administrative expenses totaled $2.2 million and $2.3 million, respectively, for the three months ended March 31, 2025 and 2024. Over the same periods, $2 thousand and $46 thousand of performance-based incentive fees were waived. Expenses generally consist of management and performance-based incentive fees, interest and other credit facility expenses, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The decrease in expenses for the year over year three month periods was primarily due to lower interest expense from a decrease in average borrowings as well as a decrease in the index rates on borrowings.

Net Investment Income

The Company’s net investment income totaled $22.1 million and $23.9 million, or $0.41 and $0.44, per average share, respectively, for the three months ended March 31, 2025 and 2024.

Net Realized Gain (Loss)

The Company had investment sales and prepayments totaling approximately $197 million and $131 million, respectively, for the three months ended March 31, 2025 and 2024. Net realized gain (loss) over the same periods were $(0.4) million and $0.1 million, respectively. Net realized gain (loss) for the three months ended March 31, 2025 and 2024 were primarily due to the disposition of selected assets.

Net Change in Unrealized Gain (Loss)

For the three months ended March 31, 2025 and 2024, net change in unrealized gain (loss) on the Company’s assets totaled $(1.8) million and $3.9 million, respectively. Net unrealized loss for the three months ended March 31, 2025 was primarily due to depreciation in the value of our investments in SLR Equipment Finance, SLR-AMI Topco Blocker, LLC and SLR Senior Lending Program LLC, among others, as well as the reversal of previously recognized unrealized appreciation upon the exit of our investments in Outset Medical, Inc. and Retina Midco, Inc., partially offset by appreciation in the value of our investments in KBH Topco, LLC, SLR Business Credit and Bayside Parent, LLC, among others. Net unrealized gain for the three months ended March 31, 2024 was primarily due to appreciation in the value of our investments in Arcutis Biotherapeutics, Inc., Neuronetics, Inc., Cerapedics, Inc., SLR Credit Solutions and SLR Healthcare ABL, among others, partially offset by depreciation in the value of our investments in SLR Equipment Finance and SOINT, LLC, among others.

Net Increase in Net Assets from Operations

For the three months ended March 31, 2025 and 2024, the Company had a net increase in net assets resulting from operations of $19.9 million and $27.9 million, respectively. For the same periods, earnings per average share were $0.37 and $0.51, respectively.

57

LIQUIDITY AND CAPITAL RESOURCES

The Company’s liquidity and capital resources are generated and generally available through its Credit Facility and SPV Credit Facility, the 2026 Unsecured Notes, the 2027 Unsecured Notes, the 2027 Series F Unsecured Notes, the 2027 Series G Unsecured Notes and the 2028 Unsecured Notes (each as defined below and, collectively, the “Debt Instruments”), through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic follow-on equity and/or debt offerings. As of March 31, 2025, we had a total of $420.7 million of collective unused borrowing capacity under the Credit Facility and SPV Credit Facility, subject to borrowing base limits.

On February 28, 2025, the Company entered into an equity distribution agreement (the “Equity Distribution Agreement”) by and among the Company, the Investment Adviser and the Administrator, on the one hand, and Raymond James & Associates, Inc., Citizens JMP Securities, LLC and Jefferies LLC, as placement agents thereunder (collectively, the “Agents”), on the other hand. Under the Equity Distribution Agreement, the Company may, but has no obligation to, issue and sell up to $150,000,000 in aggregate amount of shares of its common stock from time to time through the Agents, or to them, as principal for their own account.

For the three months ended March 31, 2025, the Company sold no shares of common stock under the Equity Distribution Agreement. As of March 31, 2025, shares representing $150,000,000 of our common stock remain available for issuance and sale under the Equity Distribution Agreement.

We may from time to time issue other equity and/or debt securities in either public or private offerings. The issuance of such securities will depend on future market conditions, funding needs and other factors and there can be no assurance that any such issuance will occur or be successful. The primary uses of existing funds and any funds raised in the future are expected to be for investments in portfolio companies, repayment of indebtedness, cash distributions to our stockholders, or for other general corporate purposes.

Debt

On February 18, 2025, the Company closed a private offering of $50 million of unsecured notes with a fixed interest rate of 6.14% and a maturity date of February 18, 2028 (the “2028 Unsecured Notes”). Interest on the 2028 Unsecured Notes is due
semi-annually on February 18 and August 18. The 2028 Unsecured Notes were issued in a private placement only to qualified
institutional buyers.

On December 16, 2024, the Company closed a private offering of $49 million of unsecured notes with a fixed interest rate of 6.24% and a maturity date of December 16, 2027 (the “2027 Series G Unsecured Notes”). Interest on the 2027 Series G Unsecured Notes is due semi-annually on June 16 and December 16. The 2027 Series G Unsecured Notes were issued in a private placement only to qualified institutional buyers.

On August 16, 2024, the Company closed on Amendment No. 3 to its August 28, 2019 senior secured credit agreement (as amended to date, the “Credit Facility”). Following this amendment and several commitment increases in the fourth quarter of 2024, the Credit Facility is now composed of $695 million of revolving credit and $140 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of 1.75%-2.00% or the alternate base rate plus 0.75%-1.00%. The Credit Facility has a 0% floor, matures in August 2029 and includes ratable amortization in the final year. Subsequent to Amendment No. 4 on December 3, 2024, the Credit Facility may be increased up to $900 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that, among other things, require the Company to maintain a minimum stockholder’s equity and a minimum asset coverage ratio. At March 31, 2025, outstanding USD equivalent borrowings under the Credit Facility totaled $536.2 million, composed of $396.2 million of revolving credit and $140.0 million of term loans.

On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85 million in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”), and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes was due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement to be performed or observed by SUNS. The 2025 Unsecured Notes were repaid in full at maturity on March 31, 2025.

On April 1, 2022, we entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to our assumption of the revolving credit facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, subsequent to an August 30, 2024 amendment, the commitment under the SPV Credit Facility is $275

58

million. The stated interest rate on the SPV Credit Facility is SOFR plus 2.25%-2.75% with no SOFR floor requirement, and the current final maturity date is August 30, 2028. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we, as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At March 31, 2025, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $153.1 million.

On January 6, 2022, the Company closed a private offering of $135 million of unsecured notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027 (the “2027 Series F Unsecured Notes”). Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.

On September 14, 2021, the Company closed a private offering of $50 million of unsecured notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027 (the “2027 Unsecured Notes”). Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.

On December 18, 2019, the Company closed a private offering of $75 million of unsecured notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026 (the “2026 Unsecured Notes”). Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.

Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. At March 31, 2025, the Company was in compliance with all financial and operational covenants required by the Debt Instruments.

Cash Equivalents

We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time to time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on the Credit Facility, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose are excluded from total assets for purposes of computing the asset base upon which the management fee is determined. We held a face amount of $450 million in cash equivalents as of March 31, 2025.

Contractual Obligations

A summary of our significant contractual payment obligations is as follows as of March 31, 2025:

Payments Due by Period (in millions)

	Total		Less than 1 Year		1-3 Years		3-5 Years		More Than 5 Years
Revolving credit facilities (1)	$	549.3	$	—	$	—	$	549.3	$	—
Unsecured senior notes		359.0		—		359.0		—		—
Term loans		140.0		—		—		140.0		—

(1)As of March 31, 2025, we had a total of $420.7 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.

Under the provisions of the 1940 Act, we are permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of gross assets less all liabilities and indebtedness not represented by

59

senior securities, after each issuance of senior securities. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss.

We have also entered into two contracts under which we have future commitments: an investment advisory and management agreement (the “Advisory Agreement”), pursuant to which the Investment Adviser has agreed to serve as our investment adviser, and an administration agreement (the “Administration Agreement”), pursuant to which the Administrator has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide on our behalf managerial assistance to those portfolio companies to which we are required to provide such assistance. Payments under the Advisory Agreement are equal to (1) a percentage of the value of our average gross assets and (2) a two-part incentive fee. Payments under the Administration Agreement are equal to an amount based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including rent, technology systems, insurance and our allocable portion of the costs of our chief financial officer and chief compliance officer and their respective staffs. Either party may terminate each of the Advisory Agreement and Administration Agreement without penalty upon 60 days written notice to the other. See Note 3 to our Consolidated Financial Statements.

On July 31, 2017, the Company, NEFPASS LLC and NEFCORP LLC entered into a servicing agreement. NEFCORP LLC was engaged to provide NEFPASS LLC with administrative services related to the loans and capital leases held by NEFPASS LLC. NEFPASS LLC may terminate this agreement upon 30 days written notice to NEFCORP LLC.

On October 7, 2022, the Company committed $50 million to SSLP and entered into a servicing agreement. SSLP engaged and retained the Company to provide certain administrative services relating to the facilities, supplies and necessary ongoing overhead support services for the operation of SSLP’s ongoing business affairs in exchange for a fee.

Senior Securities

Information about our senior securities is shown in the following table (in thousands) as of the quarter ended March 31, 2025 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.

60

Class and Year	Total Amount Outstanding(1)		Asset Coverage Per Unit(2)		Involuntary Liquidating Preference Per Unit(3)		Average Market Value Per Unit(4)
Credit Facility
Fiscal 2025 (through March 31, 2025)	$	396,210	$	735		—	N/A
Fiscal 2024		342,043		642		—	N/A
Fiscal 2023		407,000		631		—	N/A
Fiscal 2022		293,000		513		—	N/A
Fiscal 2021		222,500		552		—	N/A
Fiscal 2020		126,000		421		—	N/A
Fiscal 2019		42,900		182		—	N/A
Fiscal 2018		96,400		593		—	N/A
Fiscal 2017		245,600		1,225		—	N/A
Fiscal 2016		115,200		990		—	N/A
Fiscal 2015		207,900		1,459		—	N/A
SPV Credit Facility
Fiscal 2025 (through March 31, 2025)		153,050		284		—	N/A
Fiscal 2024		165,050		310		—	N/A
Fiscal 2023		206,250		320		—	N/A
Fiscal 2022		155,200		272		—	N/A
2022 Unsecured Notes
Fiscal 2022		—		—		—	N/A
Fiscal 2021		150,000		372		—	N/A
Fiscal 2020		150,000		501		—	N/A
Fiscal 2019		150,000		638		—	N/A
Fiscal 2018		150,000		923		—	N/A
Fiscal 2017		150,000		748		—	N/A
Fiscal 2016		50,000		430		—	N/A
2022 Tranche C Notes
Fiscal 2022		—		—		—	N/A
Fiscal 2021		21,000		52		—	N/A
Fiscal 2020		21,000		70		—	N/A
Fiscal 2019		21,000		89		—	N/A
Fiscal 2018		21,000		129		—	N/A
Fiscal 2017		21,000		105		—	N/A
2023 Unsecured Notes
Fiscal 2023		—		—		—	N/A
Fiscal 2022		75,000		131		—	N/A
Fiscal 2021		75,000		186		—	N/A
Fiscal 2020		75,000		250		—	N/A
Fiscal 2019		75,000		319		—	N/A
Fiscal 2018		75,000		461		—	N/A
Fiscal 2017		75,000		374		—	N/A
2024 Unsecured Notes
Fiscal 2024		—		—		—	N/A
Fiscal 2023		125,000		194		—	N/A
Fiscal 2022		125,000		219		—	N/A
Fiscal 2021		125,000		309		—	N/A
Fiscal 2020		125,000		417		—	N/A
Fiscal 2019		125,000		531		—	N/A
2025 Unsecured Notes
Fiscal 2025 (through March 31, 2025)		—		—		—	N/A
Fiscal 2024		85,000		159		—	N/A
Fiscal 2023		85,000		132		—	N/A
Fiscal 2022		85,000		149		—	N/A

61

Class and Year	Total Amount Outstanding(1)		Asset Coverage Per Unit(2)		Involuntary Liquidating Preference Per Unit(3)		Average Market Value Per Unit(4)
2026 Unsecured Notes
Fiscal 2025 (through March 31, 2025)	$	75,000	$	139		—	N/A
Fiscal 2024		75,000		131		—	N/A
Fiscal 2023		75,000		116		—	N/A
Fiscal 2022		75,000		131		—	N/A
Fiscal 2021		75,000		186		—	N/A
Fiscal 2020		75,000		250		—	N/A
Fiscal 2019		75,000		319		—	N/A
2027 Unsecured Notes
Fiscal 2025 (through March 31, 2025)		50,000		93		—	N/A
Fiscal 2024		50,000		94		—	N/A
Fiscal 2023		50,000		77		—	N/A
Fiscal 2022		50,000		88		—	N/A
Fiscal 2021		50,000		124		—	N/A
2027 Series F Unsecured Notes
Fiscal 2025 (through March 31, 2025)		135,000		250		—	N/A
Fiscal 2024		135,000		253		—	N/A
Fiscal 2023		135,000		209		—	N/A
Fiscal 2022		135,000		237		—	N/A
2027 Series G Unsecured Notes
Fiscal 2025 (through March 31, 2025)		49,000		91		—	N/A
Fiscal 2024		49,000		92		—	N/A
2028 Unsecured Notes
Fiscal 2025 (through March 31, 2025)		50,000		93		—	N/A
2042 Unsecured Notes
Fiscal 2017		—		—		—	N/A
Fiscal 2016		100,000		859		—	$	1,002
Fiscal 2015		100,000		702		—		982
Senior Secured Notes
Fiscal 2017		—		—		—	N/A
Fiscal 2016		75,000		645		—	N/A
Fiscal 2015		75,000		527		—	N/A
Term Loans
Fiscal 2025 (through March 31, 2025)		140,000		260		—	N/A
Fiscal 2024		140,000		263		—	N/A
Fiscal 2023		100,000		155		—	N/A
Fiscal 2022		100,000		175		—	N/A
Fiscal 2021		100,000		248		—	N/A
Fiscal 2020		75,000		250		—	N/A
Fiscal 2019		75,000		319		—	N/A
Fiscal 2018		50,000		308		—	N/A
Fiscal 2017		50,000		250		—	N/A
Fiscal 2016		50,000		430		—	N/A
Fiscal 2015		50,000		351		—	N/A
NEFPASS Facility
Fiscal 2021		—		—		—	N/A
Fiscal 2020		30,000		100		—	N/A
Fiscal 2019		30,000		128		—	N/A
Fiscal 2018		30,000		185		—	N/A
SSLP Facility
Fiscal 2019		—		—		—	N/A
Fiscal 2018		53,785		331		—	N/A
Total Senior Securities
Fiscal 2025 (through March 31, 2025)	$	1,048,260	$	1,945		—	N/A
Fiscal 2024		1,041,093		1,954		—	N/A
Fiscal 2023		1,183,250		1,834		—	N/A
Fiscal 2022		1,093,200		1,915		—	N/A
Fiscal 2021		818,500		2,029		—	N/A
Fiscal 2020		677,000		2,259		—	N/A
Fiscal 2019		593,900		2,525		—	N/A
Fiscal 2018		476,185		2,930		—	N/A
Fiscal 2017		541,600		2,702		—	N/A
Fiscal 2016		390,200		3,354		—	N/A
Fiscal 2015		432,900		3,039		—	N/A

62

(1)Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.

(2)The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of March 31, 2025, asset coverage was 194.5%.

(3)The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.

(4)Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016 and 2015 periods was $100,175 and $98,196, respectively.

63

Off-Balance Sheet Arrangements

From time to time and in the normal course of business, the Company may make unfunded capital commitments to current or prospective portfolio companies. Typically, the Company may agree to provide delayed-draw term loans or, to a lesser extent, revolving loans or equity commitments. These unfunded capital commitments always take into account the Company’s liquidity and cash available for investment, portfolio and issuer diversification, and other considerations. Accordingly, the Company had the following unfunded capital commitments at March 31, 2025 and December 31, 2024, respectively:

(in millions)	March 31, 2025		December 31, 2024
SLR Credit Solutions*	$	44.3	$	44.3
Alkeme Intermediary Holdings, LLC		25.6		—
SLR Healthcare ABL*		17.0		10.0
BDG Media, Inc.		14.3		11.8
Stella & Chewy's, LLC		13.2		—
Arcutis Biotherapeutics, Inc.		12.7		12.7
Western Veterinary Partners LLC		11.6		18.2
Plastic Management, LLC		10.8		10.8
Copper River Seafoods, Inc.		9.8		6.9
Pasadena Private Lending Inc.		8.4		8.4
SLR Business Credit*		8.0		8.0
WMD Funding LLC		7.2		7.2
One Touch Direct, LLC		7.0		8.0
Ardelyx, Inc.		6.6		6.6
United Digestive MSO Parent, LLC		6.0		7.5
Quantcast Corporation		5.9		4.1
The Townsend Company, LLC		5.7		7.9
Pinnacle Fertility, Inc.		5.3		—
33 Across Inc.		5.3		4.2
Sherwood Management Co., Inc.		4.3		—
iCIMS, Inc.		3.9		3.5
SPR Therapeutics, Inc.		3.7		6.1
Southern Transport LLC		3.6		—
CVAUSA Management, LLC		3.2		10.2
Sightly Enterprises, Inc.		2.9		2.7
Southern Lifting and Hoisting, LLC		2.6		—
SPAR Marketing Force, Inc.		2.5		5.4
Erie Construction Mid-west, LLC		2.4		2.4
SLR Senior Lending Program LLC*		2.1		2.1
Bayside Opco, LLC		2.1		2.1
DeepIntent, Inc.		1.9		7.3
SunMed Group Holdings, LLC		1.6		1.6
RxSense Holdings LLC		1.2		1.3
SLR Equipment Finance*		1.0		3.0
Tilley Distribution, Inc.		1.0		1.2
EyeSouth Eye Care Holdco LLC		1.0		1.3
Urology Management Holdings, Inc.		0.9		0.9
High Street Buyer, Inc.		0.6		0.6
CC SAG Holdings Corp. (Spectrum Automotive)		0.5		0.5
TAUC Management, LLC		0.3		0.3
Shoes for Crews Global, LLC		0.3		0.3
All States Ag Parts, LLC		0.3		0.3
Foundation Consumer Brands, LLC		—		3.0
Kaseya, Inc.		—		1.9
Total Commitments	$	268.6	$	234.6

* The Company controls the funding of these commitments and may cancel them at its discretion.

64

The credit agreements governing the above loan commitments contain customary lending provisions and/or are subject to the respective portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of March 31, 2025 and December 31, 2024, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.

In the normal course of business, we invest or trade in various financial instruments and may enter into various investment activities with off-balance sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of off-balance sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities.

Distributions

The following table reflects the cash distributions per share on our common stock for the two most recent fiscal years and the current fiscal year to date:

Date Declared	Record Date	Payment Date	Amount
Fiscal 2025
May 7, 2025	June 13, 2025	June 27, 2025	$	0.41
February 25, 2025	March 14, 2025	March 28, 2025		0.41
Total 2025			$	0.82
Fiscal 2024
November 6, 2024	December 13, 2024	December 27, 2024	$	0.41
August 7, 2024	September 13, 2024	September 27, 2024		0.41
May 8, 2024	June 13, 2024	June 27, 2024		0.41
February 27, 2024	March 14, 2024	March 28, 2024		0.41
Total 2024			$	1.64
Fiscal 2023
November 7, 2023	December 14, 2023	December 28, 2023	$	0.41
September 5, 2023	September 20, 2023	September 28, 2023		0.136667
August 8, 2023	August 18, 2023	August 30, 2023		0.136667
July 5, 2023	July 20, 2023	August 1, 2023		0.136667
June 1, 2023	June 20, 2023	June 29, 2023		0.136667
May 10, 2023	May 24, 2023	June 1, 2023		0.136667
April 4, 2023	April 20, 2023	May 2, 2023		0.136667
February 28, 2023	March 23, 2023	April 4, 2023		0.136667
February 2, 2023	February 16, 2023	March 1, 2023		0.136667
January 10, 2023	January 26, 2023	February 2, 2023		0.136667
Total 2023			$	1.64

Tax characteristics of all distributions will be reported to stockholders on Form 1099 after the end of the calendar year. Future quarterly distributions, if any, will be determined by the Board. We expect that our distributions to stockholders will generally be from accumulated net investment income, net realized capital gains or non-taxable return of capital, if any, as applicable.

We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC tax treatment, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (i.e., net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.

We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders’ cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash distributions.

65

We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, the Credit Facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a RIC. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual payment-in-kind income, which represents contractual income added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a RIC.

With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and, accordingly, distributed to stockholders.

Related Parties

We have entered into a number of business relationships with affiliated or related parties, including the following:

•We have entered into the Advisory Agreement with the Investment Adviser. Mr. Michael S. Gross, our Chairman, Co-Chief Executive Officer and President, and Mr. Bruce J. Spohler, our Co-Chief Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, the Investment Adviser. In addition, Mr. Shiraz Y. Kajee, our Chief Financial Officer and Treasurer, serves as the Chief Financial Officer for the Investment Adviser, and Mr. Guy F. Talarico, our Chief Compliance Officer and Secretary, serves as Partner, General Counsel and Chief Compliance Officer for the Investment Adviser.

•The Administrator provides us with the office facilities and administrative services necessary to conduct day-to-day operations pursuant to our Administration Agreement. We reimburse the Administrator for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and the compensation of our chief compliance officer, our chief financial officer and their respective staffs.

•We have entered into a license agreement with the Investment Adviser, pursuant to which the Investment Adviser has granted us a non-exclusive, royalty-free license to use the licensed marks “SOLAR” and “SLR”.

66

The Investment Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole or in part, with ours. For example, the Investment Adviser presently serves as investment adviser to SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured loans, including non-traditional asset-based loans and first lien loans, SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and SLR Private Credit BDC II LLC, an unlisted BDC focused on first lien senior secured floating rate loans. In addition, Mr. Gross, our Chairman, Co-Chief Executive Officer and President, Mr. Spohler, our Co-Chief Executive Officer, Chief Operating Officer and board member, Mr. Kajee, our Chief Financial Officer and Treasurer, and Mr. Talarico, our Chief Compliance Officer and Secretary, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC. The Investment Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or its affiliates may determine that we should invest side-by-side with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Investment Adviser’s allocation procedures. On June 13, 2017, the Investment Adviser received an exemptive order that permits the Company to participate in negotiated co-investment transactions with certain affiliates, in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to various conditions (the “Exemptive Order”). If the Company is unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although the Investment Adviser’s investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of the Investment Adviser.

Related party transactions may occur among us, SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL and SLR Equipment. These transactions may occur in the normal course of business. No administrative or other fees are paid to the Investment Adviser by SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL or SLR Equipment.

In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are subject to financial market risks, including changes in interest rates. Uncertainty with respect to interest rates, inflationary pressures, risks in respect of a failure to increase the U.S. debt ceiling or a downgrade in the U.S. credit rating, the war between Ukraine and Russia, certain regional bank failures, an inflationary environment, the ongoing war in the Middle East, health epidemics and pandemics and the U.S. government’s recent enactments and proposals to enact substantial tariffs introduced significant volatility in the financial markets, and the effects of this volatility have materially impacted and could continue to materially impact our market risks. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In a low interest rate environment, including a reduction of SOFR to zero, the difference between the total interest income earned on interest earning assets and the total interest expense incurred on interest bearing liabilities may be compressed, reducing our net interest income and potentially adversely affecting our operating results. Conversely, in a rising interest rate environment, such difference could potentially increase thereby increasing our net investment income. During the three months ended March 31, 2025, certain investments in our comprehensive investment portfolio had floating interest rates. These floating rate investments were primarily based on floating SOFR and typically have durations of one to three months after which they reset to current market interest rates. Additionally, some of these investments have floors. The Company also has revolving credit facilities that are generally based on floating SOFR. Assuming no changes to our balance sheet as of March 31, 2025 and no new defaults by portfolio companies, a hypothetical one percent decrease in SOFR on our comprehensive floating rate assets and liabilities would decrease our net investment income by three cents per average share over the next twelve months. Assuming no changes to our balance sheet as of March 31, 2025 and no new defaults by portfolio companies, a hypothetical one percent increase in SOFR on our comprehensive floating rate assets and liabilities would increase our net investment income by approximately three cents per average share over the next twelve months. However, we may hedge against interest rate fluctuations from time to time by using standard hedging instruments such as futures, options, swaps and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in any benefits of certain changes in interest rates with

67

respect to our portfolio of investments. At March 31, 2025, we had no interest rate hedging instruments outstanding on our balance sheet.

Increase (Decrease) in SOFR		(1.00	%)		1.00	%
Increase (Decrease) in Net Investment Income Per Share    Per Year	$	(0.03	)	$	0.03

We may also have exposure to foreign currencies through various investments. These investments are converted into U.S. dollars at the balance sheet date, exposing us to movements in foreign exchange rates. In order to reduce our exposure to fluctuations in foreign exchange rates, we may borrow from time to time in such currencies under our multi-currency revolving credit facility or enter into forward currency or similar contracts.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

As of March 31, 2025 (the end of the period covered by this report), we, including our Co-Chief Executive Officers and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the 1934 Act). Based on that evaluation, our management, including our Co-Chief Executive Officers and Chief Financial Officer, concluded that, as of March 31, 2025, our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.

(b) Changes in Internal Control Over Financial Reporting

Management has not identified any change in the Company’s internal control over financial reporting that occurred during the first quarter of 2025 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

68

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

We and our consolidated subsidiaries are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us or our consolidated subsidiaries. From time to time, we and our consolidated subsidiaries may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the February 25, 2025 filing of our Annual Report on Form 10-K (the “Annual Report”) , which could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. There have been no material changes during the period ended March 31, 2025 to the risk factors discussed in “Risk Factors” in the February 25, 2025 filing of our Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Rule 10b5-1 Trading Plans

During the fiscal quarter ended March 31, 2025, none of our directors or officers (as defined in Rule 16a-1(f) under the 1934 Act) adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the 1934 Act or any “non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K.

69

Item 6. Exhibits

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

Exhibit Number	Description
3.1	Articles of Amendment and Restatement(1)
3.2	Second Amended and Restated Bylaws(4)
4.1	Form of Common Stock Certificate(2)
4.2	Indenture, dated as of November 16, 2012, between the Registrant and U.S. Bank National Association as trustee(3)
10.1	Senior Secured Credit Agreement dated as of August 28, 2019 (as amended December 28, 2021, March 11, 2022, August 16, 2024 and December 3, 2024) among SLR Investment Corp., Citibank, N.A., as administrative agent, the lenders party thereto, JPMorgan Chase Bank, N.A., as syndication agent, and Citibank, N.A., JPMorgan Chase Bank, N.A., and Sumitomo Mitsui Banking Corporation, as joint lead bookrunners and joint lead arrangers*
10.2	Form of Seventh Supplement to Note Purchase Agreement(5)
10.3	Equity Distribution Agreement, dated February 28, 2025, by and among SLR Investment Corp., SLR Capital Partners, LLC and SLR Capital Management, LLC, on the one hand, and Raymond James & Associates, Inc., Citizens JMP Securities, LLC and Jefferies LLC, as placement agents thereunder, on the other hand(6)
23.1	Awareness Letter of Independent Registered Public Accounting Firm*
31.1	Certification of Co-Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
31.2	Certification of Co-Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
31.3	Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
32.1	Certification of Co-Chief Executive Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.**
32.2	Certification of Co-Chief Executive Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.**
32.3	Certification of Chief Financial Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.**
101.INS	Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.*
101.SCH	Inline XBRL Taxonomy Extension Schema Document*
104	Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

(1)Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 Pre-Effective Amendment No. 7 (File No. 333-148734) filed on January 7, 2010.

(2)Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 (File No. 333-148734) filed on February 9, 2010.

(3)Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 Post-Effective Amendment No. 6 (File No. 333-172968) filed on November 16, 2012.

(4)Previously filed in connection with SLR Investment Corp.’s current report on Form 8-K filed on December 1, 2021.

(5)Previously filed in connection with SLR Investment Corp.’s annual report on Form 10-K filed on February 25, 2025.

(6)Previously filed in connection with SLR Investment Corp.’s current report on Form 8-K filed on February 28, 2025.

* Filed herewith.

** Furnished herewith.

70

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on May 7, 2025.

SLR INVESTMENT CORP.
By:	/s/ MICHAEL S. GROSS
	Michael S. Gross Co-Chief Executive Officer (Principal Executive Officer)
By:	/s/ BRUCE J. SPOHLER
	Bruce J. Spohler Co-Chief Executive Officer (Principal Executive Officer)
By:	/s/ SHIRAZ Y. KAJEE
	Shiraz Y. Kajee Chief Financial Officer (Principal Financial and Accounting Officer)

71